Trait: mental or behavioural disorder

Experimental Factor Ontology (EFO) Information
Identifier EFO_0000677
Description A disease that has its basis in the disruption of mental process. [MONDO: patterns/basis_in_disruption_of_process]
Trait category
Neurological disorder
Synonyms 22 synonyms
  • Behavior Disorder
  • Brief Reactive Psychoses
  • Brief Reactive Psychosis
  • Disorder, Psychotic
  • Disorders, Psychotic
  • Mental Disorder
  • PSYCHOTIC DIS
  • Psychiatric Disorder
  • Psychoses
  • Psychoses, Brief Reactive
  • Psychosis, Brief Reactive
  • Psychotic Disorder
  • Psychotic Disorders
  • Reactive Psychoses, Brief
  • Reactive Psychosis, Brief
  • disease of mental health
  • disorder of mental process
  • mental disorder
  • mental disorders
  • mental or behavioral disorder
  • mental or behavioural disorder
  • mental process disease
Mapped terms 21 mapped terms
  • DOID:150
  • DOID:2468
  • ICD10:F99
  • ICD9:290-299.99
  • ICD9:298.8
  • ICD9:V11.9
  • MESH:D001523
  • MONDO:0005084
  • MeSH:D001523
  • MeSH:D011618
  • MedDRA:10004204
  • MedDRA:10013190
  • MedDRA:10061284
  • NCIT:C2893
  • NCIt:C2893
  • NIFSTD:birnlex_12669
  • SCTID:74732009
  • SNOMEDCT:5464005
  • SNOMEDCT:69322001
  • SNOMEDCT:74732009
  • UMLS:C0004936
Child trait(s) 25 child traits

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported
Note: This table shows all PGS for "mental or behavioural disorder" and any child terms of this trait in the EFO hierarchy by default.
Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
Scoring File (FTP Link)
PGS000025
(GRS)
PGP000015 |
Chouraki V et al. J Alzheimers Dis (2016)
Alzheimer's disease Alzheimer disease 19
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000025/ScoringFiles/PGS000025.txt.gz
PGS000026
(PHS)
PGP000016 |
Desikan RS et al. PLoS Med (2017)
Alzheimer's disease Alzheimer disease 31
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000026/ScoringFiles/PGS000026.txt.gz
PGS000053
(ALZ21_NIA-LOAD)
PGP000039 |
Tosto G et al. Neurology (2017)
Alzheimer's disease (late onset) late-onset Alzheimer's disease 21
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000053/ScoringFiles/PGS000053.txt.gz
PGS000054
(ALZ21_EFIGA)
PGP000039 |
Tosto G et al. Neurology (2017)
Alzheimer's disease (late onset) late-onset Alzheimer's disease 21
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000054/ScoringFiles/PGS000054.txt.gz
PGS000133
(SCZ_BVU)
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Schizophrenia schizophrenia 604,645
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000133/ScoringFiles/PGS000133.txt.gz
PGS000134
(SCZ_GHS)
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Schizophrenia schizophrenia 830,589
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000134/ScoringFiles/PGS000134.txt.gz
PGS000135
(SCZ_MTS)
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Schizophrenia schizophrenia 972,439
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000135/ScoringFiles/PGS000135.txt.gz
PGS000136
(SCZ_PBK)
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Schizophrenia schizophrenia 833,502
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000136/ScoringFiles/PGS000136.txt.gz
PGS000138
(LifetimeMDD)
PGP000068 |
Cai N et al. Nat Genet (2020)
Lifetime Major Depressive Disorder major depressive disorder 22,274
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000138/ScoringFiles/PGS000138.txt.gz
PGS000139
(MDDRecur)
PGP000068 |
Cai N et al. Nat Genet (2020)
Lifetime Major Depressive Disorder (with recurrence) recurrent,
major depressive disorder
21,980
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000139/ScoringFiles/PGS000139.txt.gz
PGS000140
(GPpsy)
PGP000068 |
Cai N et al. Nat Genet (2020)
Broad Depression (seen a General Practitioner for nerves, anxiety, tension or depression) seeing a general practitioner for nerves, anxiety, tension or depression, self-reported,
depressive disorder
24,665
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000140/ScoringFiles/PGS000140.txt.gz
PGS000141
(Psypsy)
PGP000068 |
Cai N et al. Nat Genet (2020)
Seen a psychiatrist for nerves, anxiety, tension or depression seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported,
depressive disorder
22,728
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000141/ScoringFiles/PGS000141.txt.gz
PGS000142
(DepAll)
PGP000068 |
Cai N et al. Nat Genet (2020)
Probable Depression (low mood or anhedonia, and seen a GP or psychiatrist for nerves, anxiety, tension or depression) seeing a general practitioner for nerves, anxiety, tension or depression, self-reported,
seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported,
depressive disorder
21,908
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000142/ScoringFiles/PGS000142.txt.gz
PGS000145
(ICD10Dep)
PGP000068 |
Cai N et al. Nat Genet (2020)
Depression (ICD-10 defined) major depressive disorder 21,510
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000145/ScoringFiles/PGS000145.txt.gz
PGS000193
(MDD_0.001_Coleman_2020)
PGS000080 |
Coleman JRI et al. Mol Psychiatry (2020)
Major depression major depressive disorder 1,138
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000193/ScoringFiles/PGS000193.txt.gz
PGS000327
(ASD2019)
PGP000098 |
Grove J et al. Nat Genet (2019)
Autism spectrum disorder autism spectrum disorder 35,087
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000327/ScoringFiles/PGS000327.txt.gz
PGS000334
(GRSfull_22)
PGP000101 |
Zhang Q et al. Nat Commun (2020)
Late-onset Alzheimer’s disease late-onset Alzheimer's disease 22
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000334/ScoringFiles/PGS000334.txt.gz
PGS000756
(GRS3_Nar)
PGP000162 |
Ouyang H et al. Ann Transl Med (2020)
Narcolepsy narcolepsy-cataplexy syndrome 32
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000756/ScoringFiles/PGS000756.txt.gz
PGS000757
(GRS4_Nar)
PGP000162 |
Ouyang H et al. Ann Transl Med (2020)
Narcolepsy narcolepsy-cataplexy syndrome 5
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000757/ScoringFiles/PGS000757.txt.gz
PGS000767
(GRS14)
PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
Depression unipolar depression,
depressive symptom measurement
14
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000767/ScoringFiles/PGS000767.txt.gz
PGS000779
(PGS7_AD)
PGP000183 |
Zhou X et al. Alzheimers Dement (Amst) (2020)
Alzheimer's disease Alzheimer disease 7
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000779/ScoringFiles/PGS000779.txt.gz
PGS000811
(AD-PRS_39)
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Alzheimer's disease Alzheimer disease 39
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000811/ScoringFiles/PGS000811.txt.gz
PGS000812
(AD-PRS_57)
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Alzheimer's disease Alzheimer disease 57
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000812/ScoringFiles/PGS000812.txt.gz
PGS000823
(GRS23_AD)
PGP000207 |
van der Lee SJ et al. Lancet Neurol (2018)
Alzheimer's disease Alzheimer disease 23
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000823/ScoringFiles/PGS000823.txt.gz
PGS000876
(PRS31_AD)
PGP000222 |
Leonenko G et al. Ann Clin Transl Neurol (2019)
Alzheimer's disease Alzheimer disease 31
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000876/ScoringFiles/PGS000876.txt.gz
PGS000898
(PRS39_AD)
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Alzheimer's disease Alzheimer disease 40
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000898/ScoringFiles/PGS000898.txt.gz
PGS000907
(PRS_MDD)
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Major depressive disorder major depressive disorder 1,773,528
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000907/ScoringFiles/PGS000907.txt.gz
PGS000908
(PRS_Insomnia)
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Insomnia insomnia 2,746,982
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000908/ScoringFiles/PGS000908.txt.gz
PGS000926
(GBE_QT_FC1001220)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Daytime dozing / sleeping (narcolepsy) narcolepsy 4,194
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000926/ScoringFiles/PGS000926.txt.gz
PGS000929
(GBE_HC1583)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
All-cause dementia (algorithmically-defined) dementia 6
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000929/ScoringFiles/PGS000929.txt.gz
PGS000945
(GBE_HC710)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Dementia in Alzheimer's disease (time-to-event) dementia,
Alzheimer disease
26
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000945/ScoringFiles/PGS000945.txt.gz
PGS000946
(GBE_HC713)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Unspecified dementia (time-to-event) dementia 9
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000946/ScoringFiles/PGS000946.txt.gz
PGS001179
(GBE_HC711)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Vascular dementia (time-to-event) vascular dementia 7
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001179/ScoringFiles/PGS001179.txt.gz
PGS001348
(GBE_HC1584)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Alzheimer's disease (algorithmically-defined) Alzheimer disease 15
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001348/ScoringFiles/PGS001348.txt.gz
PGS001349
(GBE_HC807)
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Alzheimer's disease (time-to-event) Alzheimer disease 6
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001349/ScoringFiles/PGS001349.txt.gz
PGS001775
(PRS39_AD)
PGP000255 |
Ebenau JL et al. Alzheimers Dement (Amst) (2021)
Alzheimer's disease Alzheimer disease 39
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001775/ScoringFiles/PGS001775.txt.gz
PGS001827
(portability-PLR_290.1)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Dementia dementia 33
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001827/ScoringFiles/PGS001827.txt.gz
PGS001828
(portability-PLR_290.11)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Alzheimer's disease Alzheimer disease 38
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001828/ScoringFiles/PGS001828.txt.gz
PGS001829
(portability-PLR_296.2)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Depression depressive disorder 7,534
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001829/ScoringFiles/PGS001829.txt.gz
PGS001830
(portability-PLR_318)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Tobacco use disorder nicotine dependence 13,838
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001830/ScoringFiles/PGS001830.txt.gz
PGS001932
(portability-PLR_insomnia)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Sleeplessness / insomnia insomnia 37,712
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001932/ScoringFiles/PGS001932.txt.gz
PGS001995
(portability-PLR_narcolepsy)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Daytime dozing / sleeping (narcolepsy) narcolepsy 27,143
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001995/ScoringFiles/PGS001995.txt.gz
PGS002035
(portability-ldpred2_290.1)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Dementia dementia 39,752
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002035/ScoringFiles/PGS002035.txt.gz
PGS002036
(portability-ldpred2_296.2)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Depression depressive disorder 807,338
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002036/ScoringFiles/PGS002036.txt.gz
PGS002037
(portability-ldpred2_318)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Tobacco use disorder nicotine dependence 847,691
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002037/ScoringFiles/PGS002037.txt.gz
PGS002098
(portability-ldpred2_abnormal_appetite)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Recent poor appetite or overeating eating disorder 764,146
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002098/ScoringFiles/PGS002098.txt.gz
PGS002144
(portability-ldpred2_hard_falling_asleep)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Trouble falling asleep Sleep Disorder 539,784
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002144/ScoringFiles/PGS002144.txt.gz
PGS002149
(portability-ldpred2_insomnia)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Sleeplessness / insomnia insomnia 926,585
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002149/ScoringFiles/PGS002149.txt.gz
PGS002212
(portability-ldpred2_narcolepsy)
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Daytime dozing / sleeping (narcolepsy) narcolepsy 893,802
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002212/ScoringFiles/PGS002212.txt.gz
PGS002249
(AD_PRS_0.5)
PGP000276 |
Lourida I et al. JAMA (2019)
Alzheimer's disease Alzheimer disease 249,273
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002249/ScoringFiles/PGS002249.txt.gz
PGS002280
(GRS83_AD)
PGP000309 |
Bellenguez C et al. Nat Genet (2022)
Alzheimer's disease Alzheimer disease 83
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002280/ScoringFiles/PGS002280.txt.gz
PGS002289
(GRS23_AD)
PGP000316 |
Zimmerman SC et al. JAMA Netw Open (2022)
Late-onset Alzheimer's disease late-onset Alzheimer's disease 23
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002289/ScoringFiles/PGS002289.txt.gz
PGS002731
(oA-PRS)
PGP000339 |
Xicota L et al. Neurology (2022)
Alzheimer's disease Alzheimer disease 17
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002731/ScoringFiles/PGS002731.txt.gz
PGS002738
(PRS_AUD)
PGP000345 |
Lai D et al. Alcohol Clin Exp Res (2022)
Alcohol use disorder alcohol dependence 326,000
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002738/ScoringFiles/PGS002738.txt.gz
PGS002739
(PRS_gene)
PGP000346 |
Lai D et al. Transl Psychiatry (2022)
Alcohol use disorder alcohol dependence 858
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002739/ScoringFiles/PGS002739.txt.gz
PGS002746
(PRS_ADHD)
PGP000358 |
Lahey BB et al. J Psychiatr Res (2022)
Attention-deficit hyperactivity disorder attention deficit hyperactivity disorder 513,659
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002746/ScoringFiles/PGS002746.txt.gz
PGS002753
(Alzheimer_s_disease_prscs)
PGP000364 |
Mars N et al. Am J Hum Genet (2022)
Alzheimer's disease Alzheimer disease 1,092,011
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002753/ScoringFiles/PGS002753.txt.gz
PGS002759
(Depression_prscs)
PGP000364 |
Mars N et al. Am J Hum Genet (2022)
Depression unipolar depression 1,091,613
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002759/ScoringFiles/PGS002759.txt.gz
PGS002785
(SCZ_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Schizophrenia schizophrenia 964,422
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002785/ScoringFiles/PGS002785.txt.gz
PGS002786
(BD_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Bipolar disorder bipolar disorder 948,996
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002786/ScoringFiles/PGS002786.txt.gz
PGS002787
(BD1_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Type 1 bipolar disorder bipolar I disorder 937,511
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002787/ScoringFiles/PGS002787.txt.gz
PGS002788
(BD2_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Type 2 bipolar disorder bipolar II disorder 935,292
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002788/ScoringFiles/PGS002788.txt.gz
PGS002789
(MDD_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Major depressive disorder major depressive disorder 943,784
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002789/ScoringFiles/PGS002789.txt.gz
PGS002790
(ASD_SDPR)
PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
Autism spectrum disorder autism spectrum disorder 916,713
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002790/ScoringFiles/PGS002790.txt.gz
PGS003204
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_LASSOSUM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 4,360
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003204/ScoringFiles/PGS003204.txt.gz
PGS003205
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_PT_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 5,300
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003205/ScoringFiles/PGS003205.txt.gz
PGS003206
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_PLINK_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 9,873
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003206/ScoringFiles/PGS003206.txt.gz
PGS003207
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_DBSLMM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 355
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003207/ScoringFiles/PGS003207.txt.gz
PGS003208
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_PRSCS_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 12,076
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003208/ScoringFiles/PGS003208.txt.gz
PGS003209
(ExPRSweb_SleepApnea_G6-SLEEPAPNO_LASSOSUM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 328,671
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003209/ScoringFiles/PGS003209.txt.gz
PGS003210
(ExPRSweb_SleepApnea_G6-SLEEPAPNO_PT_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 40,992
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003210/ScoringFiles/PGS003210.txt.gz
PGS003211
(ExPRSweb_SleepApnea_G6-SLEEPAPNO_PLINK_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 39,223
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003211/ScoringFiles/PGS003211.txt.gz
PGS003212
(ExPRSweb_SleepApnea_G6-SLEEPAPNO_DBSLMM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 7,601,206
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003212/ScoringFiles/PGS003212.txt.gz
PGS003213
(ExPRSweb_SleepApnea_G6-SLEEPAPNO_PRSCS_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 1,111,194
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003213/ScoringFiles/PGS003213.txt.gz
PGS003214
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_LASSOSUM_UKB_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 5,812
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003214/ScoringFiles/PGS003214.txt.gz
PGS003215
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_PT_UKB_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 1,209
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003215/ScoringFiles/PGS003215.txt.gz
PGS003216
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_PLINK_UKB_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 688
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003216/ScoringFiles/PGS003216.txt.gz
PGS003217
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_DBSLMM_UKB_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 46
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003217/ScoringFiles/PGS003217.txt.gz
PGS003218
(ExPRSweb_SleepApnea_finngen-R4-G6-SLEEPAPNO_PRSCS_UKB_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Sleep apnea sleep apnea 12,097
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003218/ScoringFiles/PGS003218.txt.gz
PGS003319
(ExPRSweb_Insomnia_1160_LASSOSUM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 578,551
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003319/ScoringFiles/PGS003319.txt.gz
PGS003320
(ExPRSweb_Insomnia_1160_PT_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 147
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003320/ScoringFiles/PGS003320.txt.gz
PGS003321
(ExPRSweb_Insomnia_1160_PLINK_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 148
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003321/ScoringFiles/PGS003321.txt.gz
PGS003322
(ExPRSweb_Insomnia_1160_DBSLMM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 8,590,163
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003322/ScoringFiles/PGS003322.txt.gz
PGS003323
(ExPRSweb_Insomnia_1160_PRSCS_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 1,113,832
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003323/ScoringFiles/PGS003323.txt.gz
PGS003324
(ExPRSweb_Insomnia_1200_LASSOSUM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 464,576
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003324/ScoringFiles/PGS003324.txt.gz
PGS003325
(ExPRSweb_Insomnia_1200_PT_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 28,289
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003325/ScoringFiles/PGS003325.txt.gz
PGS003326
(ExPRSweb_Insomnia_1200_PLINK_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 27,462
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003326/ScoringFiles/PGS003326.txt.gz
PGS003327
(ExPRSweb_Insomnia_1200_DBSLMM_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 6,214,923
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003327/ScoringFiles/PGS003327.txt.gz
PGS003328
(ExPRSweb_Insomnia_1200_PRSCS_MGI_20211120)
PGP000393 |
Ma Y et al. Am J Hum Genet (2022)
Insomnia insomnia 1,065,129
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003328/ScoringFiles/PGS003328.txt.gz
PGS003333
(MDD-PRS)
PGP000399 |
Fang Y et al. Biol Psychiatry (2022)
Major Depressive Disorder major depressive disorder 1,088,415
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003333/ScoringFiles/PGS003333.txt.gz
PGS003334
(PRS_dementia)
PGP000402 |
Chen Y et al. Arch Gerontol Geriatr (2022)
Dementia dementia 27
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003334/ScoringFiles/PGS003334.txt.gz
PGS003414
(PRS47_RBD)
PGP000427 |
Krohn L et al. Nat Commun (2022)
REM sleep behavior disorder REM sleep behavior disorder 47
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003414/ScoringFiles/PGS003414.txt.gz
PGS003440
(GRS11_nonapoeAD)
PGP000444 |
Petrican R et al. Sci Rep (2023)
Alzheimer's disease in non APOE APOE carrier status,
Alzheimer disease
11
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003440/ScoringFiles/PGS003440.txt.gz
PGS003441
(GRS28_AD)
PGP000444 |
Petrican R et al. Sci Rep (2023)
Alzheimer's disease Alzheimer disease 28
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003441/ScoringFiles/PGS003441.txt.gz
PGS003442
(GRS8_MD)
PGP000444 |
Petrican R et al. Sci Rep (2023)
Major depressive disorder major depressive disorder 8
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003442/ScoringFiles/PGS003442.txt.gz
PGS003479
(LDPred2_SleepApnea)
PGP000456 |
Zhang Y et al. EBioMedicine (2022)
Obstructive sleep apnea obstructive sleep apnea 836,839
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003479/ScoringFiles/PGS003479.txt.gz
PGS003574
(GRS_Dementia21)
PGP000459 |
Mukadam N et al. PLoS One (2022)
Alzheimer's disease (late onset) Alzheimer disease 21
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003574/ScoringFiles/PGS003574.txt.gz
PGS003576
(AutoImpAll.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003576/ScoringFiles/PGS003576.txt.gz
PGS003577
(AutoImpOnly.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003577/ScoringFiles/PGS003577.txt.gz
PGS003578
(MTAG.All.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 4,786,322
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003578/ScoringFiles/PGS003578.txt.gz
PGS003579
(MTAG.AllDep.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 4,786,322
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003579/ScoringFiles/PGS003579.txt.gz
PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 4,786,322
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003580/ScoringFiles/PGS003580.txt.gz
PGS003581
(MTAG.Envs.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 4,861,398
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003581/ScoringFiles/PGS003581.txt.gz
PGS003582
(MTAG.FamHist.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 4,861,398
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003582/ScoringFiles/PGS003582.txt.gz
PGS003583
(MTAG.GPpsy.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 4,861,398
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003583/ScoringFiles/PGS003583.txt.gz
PGS003584
(SoftImpAll.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003584/ScoringFiles/PGS003584.txt.gz
PGS003585
(SoftImpOnly.LifetimeMDD)
PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre
Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003585/ScoringFiles/PGS003585.txt.gz
PGS003753
(PRS35445_ADHD)
PGP000473 |
Sato JR et al. Genes Brain Behav (2023)
Attention deficit hyperactivity disorder attention deficit hyperactivity disorder 35,445
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003753/ScoringFiles/PGS003753.txt.gz
PGS003857
(GRS18_BMIunadj)
PGP000496 |
Sofer T et al. EBioMedicine (2023)
Obstructive sleep apnea obstructive sleep apnea 18
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003857/ScoringFiles/PGS003857.txt.gz
PGS003858
(GRS6_BMIadj)
PGP000496 |
Sofer T et al. EBioMedicine (2023)
Obstructive sleep apnea (BMI adjusted) obstructive sleep apnea 6
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003858/ScoringFiles/PGS003858.txt.gz
PGS003953
(AD_Bellenguez)
PGP000503 |
Sofer T et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 1,937
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003953/ScoringFiles/PGS003953.txt.gz
PGS003954
(AD_FINNGEN)
PGP000503 |
Sofer T et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 81
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003954/ScoringFiles/PGS003954.txt.gz
PGS003955
(AD_Jun)
PGP000503 |
Sofer T et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 85
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003955/ScoringFiles/PGS003955.txt.gz
PGS003956
(AD_Kunkle_AFR)
PGP000503 |
Sofer T et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 157
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003956/ScoringFiles/PGS003956.txt.gz
PGS003957
(AD_Kunkle)
PGP000503 |
Sofer T et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 12,002
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003957/ScoringFiles/PGS003957.txt.gz
PGS003958
(AD_Unweighted_PRSsum)
PGP000503 |
Sofer T et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 14,109
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003958/ScoringFiles/PGS003958.txt.gz
PGS003992
(dbslmm.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 1,136,212
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003992/ScoringFiles/PGS003992.txt.gz
PGS004008
(lassosum.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 5,663
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004008/ScoringFiles/PGS004008.txt.gz
PGS004034
(ldpred2.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 1,046,908
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004034/ScoringFiles/PGS004034.txt.gz
PGS004062
(megaprs.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 691,136
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004062/ScoringFiles/PGS004062.txt.gz
PGS004092
(prscs.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 1,109,233
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004092/ScoringFiles/PGS004092.txt.gz
PGS004116
(pt_clump.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 58
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004116/ScoringFiles/PGS004116.txt.gz
PGS004146
(sbayesr.auto.GCST90012877.AD)
PGP000517 |
Monti M R et al. medRxiv (2023)
|Pre
Alzheimer's disease Alzheimer disease 915,771
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004146/ScoringFiles/PGS004146.txt.gz
PGS004227
(ad_apoe_gw_pgs)
PGP000527 |
Green RE et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 15
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004227/ScoringFiles/PGS004227.txt.gz
PGS004228
(ad_apoe_0.1_pgs)
PGP000527 |
Green RE et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 8,863
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004228/ScoringFiles/PGS004228.txt.gz
PGS004229
(ad_noapoe_0.1_pgs)
PGP000527 |
Green RE et al. Alzheimers Res Ther (2023)
Alzheimer's disease Alzheimer disease 8,858
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004229/ScoringFiles/PGS004229.txt.gz
PGS004318
(PRS29_dementia)
PGP000548 |
Feng J et al. BMC Geriatr (2023)
Dementia dementia 29
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004318/ScoringFiles/PGS004318.txt.gz
PGS004449
(disease.F10.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
F10 (Mental and behavioural disorders due to use of alcohol) alcohol-induced mental disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004449/ScoringFiles/PGS004449.txt.gz
PGS004450
(disease.F17.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
F17 (Mental and behavioural disorders due to use of tobacco) mental or behavioural disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004450/ScoringFiles/PGS004450.txt.gz
PGS004451
(disease.F41.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
F41 (Other anxiety disorders) anxiety disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004451/ScoringFiles/PGS004451.txt.gz
PGS004452
(disease.G47.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
G47 (Sleep disorders) Sleep Disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004452/ScoringFiles/PGS004452.txt.gz
PGS004519
(meta.F10.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
F10 (Mental and behavioural disorders due to use of alcohol) alcohol-induced mental disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004519/ScoringFiles/PGS004519.txt.gz
PGS004520
(meta.F17.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
F17 (Mental and behavioural disorders due to use of tobacco) mental or behavioural disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004520/ScoringFiles/PGS004520.txt.gz
PGS004521
(meta.F41.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
F41 (Other anxiety disorders) anxiety disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004521/ScoringFiles/PGS004521.txt.gz
PGS004522
(meta.G47.score)
PGP000561 |
Jung H et al. Commun Biol (2024)
G47 (Sleep disorders) Sleep Disorder 1,059,939
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004522/ScoringFiles/PGS004522.txt.gz
PGS004588
(PRS39_Eur)
PGP000567 |
Jung SH et al. JAMA Netw Open (2022)
Alzheimer's disease Alzheimer disease 39
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004588/ScoringFiles/PGS004588.txt.gz
PGS004589
(PRS80_trans)
PGP000567 |
Jung SH et al. JAMA Netw Open (2022)
Alzheimer's disease Alzheimer disease 80
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004589/ScoringFiles/PGS004589.txt.gz
PGS004590
(PRS363_rand_eff)
PGP000569 |
Lake J et al. Mol Psychiatry (2023)
Alzheimer's disease Alzheimer disease 363
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004590/ScoringFiles/PGS004590.txt.gz
PGS004591
(PRS17_MDD)
PGP000570 |
Li D et al. BMC Med (2023)
Major depressive disorder unipolar depression 17
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004591/ScoringFiles/PGS004591.txt.gz
PGS004600
(PRS_AD83)
PGP000578 |
Tomassen J et al. BMC Neurol (2022)
Alzheimer's disease Alzheimer disease 83
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004600/ScoringFiles/PGS004600.txt.gz
PGS004759
(depression_PRSmix_eur)
PGP000604 |
Truong B et al. Cell Genom (2024)
Depression unipolar depression 1,538,576
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004759/ScoringFiles/PGS004759.txt.gz
PGS004760
(depression_PRSmixPlus_eur)
PGP000604 |
Truong B et al. Cell Genom (2024)
Depression unipolar depression 2,141,267
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004760/ScoringFiles/PGS004760.txt.gz
PGS004863
(PRS74_AD)
PGP000609 |
Sleiman PM et al. Alzheimers Dement (2023)
Alzheimer's disease Alzheimer disease 74
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004863/ScoringFiles/PGS004863.txt.gz
PGS004898
(PRS_AD)
PGP000624 |
Vasiljevic E et al. Alzheimers Dement (2023)
Alzheimer's disease Alzheimer disease 44
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004898/ScoringFiles/PGS004898.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM000051 PGS000025
(GRS)
PSS000034|
European Ancestry|
4,353 individuals
PGP000015 |
Chouraki V et al. J Alzheimers Dis (2016)
Reported Trait: Incident Alzheimer's disease in APOE Ɛ4 carriers HR: 1.24 [1.15, 1.34] ΔC-index between models with and without GRS: 0.0112 [0.0015, 0.0208] age at baseline, sex, education level HRs are derived from a meta-analysis of studies (adjusted for study center, and participant relatedness)
PPM000052 PGS000025
(GRS)
PSS000035|
European Ancestry|
15,334 individuals
PGP000015 |
Chouraki V et al. J Alzheimers Dis (2016)
Reported Trait: Incident Alzheimer's disease in APOE Ɛ4 non-carriers HR: 1.13 [1.08, 1.18] ΔC-index between models with and without GRS: 0.0018 [-0.0003, 0.0039] age at baseline, sex, education level HRs are derived from a meta-analysis of studies (adjusted for study center, and participant relatedness)
PPM000050 PGS000025
(GRS)
PSS000033|
European Ancestry|
19,687 individuals
PGP000015 |
Chouraki V et al. J Alzheimers Dis (2016)
Reported Trait: Incident Alzheimer's disease HR: 1.17 [1.13, 1.21] ΔC-index between models with and without GRS: 0.0043 [0.0019, 0.0067] age at baseline, sex, education level, APOE Ɛ4 status HRs are derived from a meta-analysis of studies (adjusted for study center, and participant relatedness)
PPM000053 PGS000026
(PHS)
PSS000036|
European Ancestry|
17,956 individuals
PGP000016 |
Desikan RS et al. PLoS Med (2017)
Reported Trait: Alzheimer disease r (correlation between between binned quantiles of PHS-predicted and empirical age of AD onset): 0.9 APOE risk alleles (e2 and e4), age, sex, genetic PCs 1-5
PPM002504 PGS000026
(PHS)
PSS001127|
European Ancestry|
8,415 individuals
PGP000222 |
Leonenko G et al. Ann Clin Transl Neurol (2019)
|Ext.
Reported Trait: Age at Alzheimer's disease onset β: 0.11 (0.02) Gender, PCs (1-3), APOE(ε2 + ε4) Due to SNP availability issues in the dataset, only 25 out of the 31 variants in Desikan et al's polygenic hazard score (PGS000026) were used. No APOE alleles were included
PPM014811 PGS000026
(PHS)
PSS009898|
Ancestry Not Reported|
780 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in neocortical region β: 19.98 [14.3, 25.7]
PPM014812 PGS000026
(PHS)
PSS009898|
Ancestry Not Reported|
780 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in posterior cingulate region β: 25.54 [18.4, 32.6]
PPM014814 PGS000026
(PHS)
PSS009900|
Ancestry Not Reported|
278 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in neocortical region (in APOE E4 carriers) β: 25.28 [17.4, 33.2]
PPM014815 PGS000026
(PHS)
PSS009900|
Ancestry Not Reported|
278 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in posterior cingulate region (in APOE E4 carriers) β: 33.06 [23.3, 42.8]
PPM014816 PGS000026
(PHS)
PSS009900|
Ancestry Not Reported|
278 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in frontal cortex region (in APOE E4 carriers) β: 26.63 [18.0, 35.3]
PPM014817 PGS000026
(PHS)
PSS009899|
Ancestry Not Reported|
502 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in neocortical region (in APOE E4 non-carriers) β: 12.61 [3.9, 21.3]
PPM014818 PGS000026
(PHS)
PSS009899|
Ancestry Not Reported|
502 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in posterior cingulate region (in APOE E4 non-carriers) β: 14.28 [3.42, 25.1]
PPM014819 PGS000026
(PHS)
PSS009899|
Ancestry Not Reported|
502 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in frontal cortex region (in APOE E4 non-carriers) β: 13.62 [4.24, 23.0]
PPM014813 PGS000026
(PHS)
PSS009898|
Ancestry Not Reported|
780 individuals
PGP000340 |
Vacher M et al. BMC Genomics (2022)
|Ext.
Reported Trait: Aβ-amyloid deposition in frontal cortex region β: 21.19 [15.0, 27.4]
PPM000137 PGS000053
(ALZ21_NIA-LOAD)
PSS000085|
European Ancestry|
4,792 individuals
PGP000039 |
Tosto G et al. Neurology (2017)
Reported Trait: Alzheimer's disease (age-at-onset) β: -0.7 (0.15) years
PPM000133 PGS000053
(ALZ21_NIA-LOAD)
PSS000085|
European Ancestry|
4,792 individuals
PGP000039 |
Tosto G et al. Neurology (2017)
Reported Trait: Familial late-onset Alzheimer's disease (LOAD) OR: 1.29 [1.21, 1.37] Age, sex
PPM000134 PGS000053
(ALZ21_NIA-LOAD)
PSS000085|
European Ancestry|
4,792 individuals
PGP000039 |
Tosto G et al. Neurology (2017)
Reported Trait: Familial late-onset Alzheimer's disease (LOAD) OR: 1.29 [1.21, 1.38] Age, sex, APOE e4
PPM000138 PGS000054
(ALZ21_EFIGA)
PSS000084|
Hispanic or Latin American Ancestry|
3,324 individuals
PGP000039 |
Tosto G et al. Neurology (2017)
Reported Trait: Alzheimer's disease (age-at-onset) β: -0.86 (0.15) years
PPM000135 PGS000054
(ALZ21_EFIGA)
PSS000084|
Hispanic or Latin American Ancestry|
3,324 individuals
PGP000039 |
Tosto G et al. Neurology (2017)
Reported Trait: Familial late-onset Alzheimer's disease (LOAD) OR: 1.73 [1.57, 1.93] Age, sex
PPM000136 PGS000054
(ALZ21_EFIGA)
PSS000084|
Hispanic or Latin American Ancestry|
3,324 individuals
PGP000039 |
Tosto G et al. Neurology (2017)
Reported Trait: Familial late-onset Alzheimer's disease (LOAD) OR: 1.71 [1.55, 1.9] Age, sex, APOE e4
PPM000417 PGS000133
(SCZ_BVU)
PSS000238|
European Ancestry|
33,694 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Psychosis OR: 1.3755 age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000413 PGS000133
(SCZ_BVU)
PSS000237|
European Ancestry|
33,694 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Schizophrenia OR: 1.691 AUROC: 0.6 [0.55, 0.66] age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000418 PGS000134
(SCZ_GHS)
PSS000240|
European Ancestry|
44,436 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Psychosis OR: 1.2224 age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000414 PGS000134
(SCZ_GHS)
PSS000239|
European Ancestry|
44,436 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Schizophrenia OR: 1.483 AUROC: 0.6 [0.56, 0.64] age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000415 PGS000135
(SCZ_MTS)
PSS000241|
European Ancestry|
9,569 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Schizophrenia AUROC: 0.74 [0.67, 0.81] age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000420 PGS000136
(SCZ_PBK)
PSS000244|
European Ancestry|
18,461 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Psychosis OR: 1.4768 age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000416 PGS000136
(SCZ_PBK)
PSS000243|
European Ancestry|
18,461 individuals
PGP000065 |
Zheutlin AB et al. Am J Psychiatry (2019)
Reported Trait: Schizophrenia OR: 1.7 AUROC: 0.64 [0.6, 0.69] age, sex, 10 PCs of ancestry, genotyping platform, genotyping batch *SNP weights were adjusted for use in this cohort
PPM000430 PGS000138
(LifetimeMDD)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.5611 : 0.01817 Cohort
PPM000431 PGS000139
(MDDRecur)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.54874 : 0.01097 Cohort
PPM000432 PGS000140
(GPpsy)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.53193 : 0.00481 Cohort
PPM000433 PGS000141
(Psypsy)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.52988 : 0.00438 Cohort
PPM000434 PGS000142
(DepAll)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.5333 : 0.00492 Cohort
PPM000437 PGS000145
(ICD10Dep)
PSS000250|
European Ancestry|
36,709 individuals
PGP000068 |
Cai N et al. Nat Genet (2020)
Reported Trait: Major Depressive Disorder status AUROC: 0.5251 : 0.0032 Cohort
PPM000564 PGS000193
(MDD_0.001_Coleman_2020)
PSS000294|
European Ancestry|
92,957 individuals
PGS000080 |
Coleman JRI et al. Mol Psychiatry (2020)
Reported Trait: Major depressive disorder OR: 1.179 : 0.01485
Nagelkerke pseudo-R2 (increase when adding PRS to null model of covariates): 0.00785
batch, centre, genomic prinicipal components (x6)
PPM000879 PGS000327
(ASD2019)
PSS000435|
European Ancestry|
7,148 individuals
PGP000098 |
Grove J et al. Nat Genet (2019)
Reported Trait: Autism spectrum disorder OR: 1.33 [1.3, 1.36] : 0.0245 Genetic PCs, genotyping wave *Pooled cross-validation performance on 1/5th of iPSYCH sample. PRS is based on full iPSYCH+PGC GWAS
PPM000901 PGS000334
(GRSfull_22)
PSS000449|
European Ancestry|
3,810 individuals
PGP000101 |
Zhang Q et al. Nat Commun (2020)
Reported Trait: Late-onset Alzheimer’s disease : 0.191 [0.131, 0.269] R2 = variance explained on the liability scale
PPM001925 PGS000756
(GRS3_Nar)
PSS000966|
East Asian Ancestry|
2,884 individuals
PGP000162 |
Ouyang H et al. Ann Transl Med (2020)
Reported Trait: Incident narcolepsy OR: 1.149 [1.119, 1.181] Odds Ratio (OR, high vs low risk): 2.586 [2.109, 3.173] Individuals with a high polygenic risk had a score ≥28. Individuals with a low polygenic risk had a score <25.
PPM001926 PGS000756
(GRS3_Nar)
PSS000966|
East Asian Ancestry|
2,884 individuals
PGP000162 |
Ouyang H et al. Ann Transl Med (2020)
Reported Trait: Incident narcolepsy OR: 1.152 [1.12, 1.185] AUROC: 0.723 Odds Ratio (OR, high vs low risk): 2.602 [2.097, 3.232] Gender Individuals with a high polygenic risk had a score ≥28. Individuals with a low polygenic risk had a score <25.
PPM001927 PGS000757
(GRS4_Nar)
PSS000966|
East Asian Ancestry|
2,884 individuals
PGP000162 |
Ouyang H et al. Ann Transl Med (2020)
Reported Trait: Incident narcolepsy OR: 1.449 [1.367, 1.536] Odds Ratio (OR, high vs low risk): 4.298 [3.378, 5.481] Individuals with a high polygenic risk had a score ≥8. Individuals with a low polygenic risk had a score <6.
PPM001928 PGS000757
(GRS4_Nar)
PSS000966|
East Asian Ancestry|
2,884 individuals
PGP000162 |
Ouyang H et al. Ann Transl Med (2020)
Reported Trait: Incident narcolepsy OR: 1.442 [1.357, 1.534] AUROC: 0.736 Odds Ratio (OR, high vs low risk): 4.157 [3.224, 5.371] Gender Individuals with a high polygenic risk had a score ≥8. Individuals with a low polygenic risk had a score <6.
PPM001972 PGS000767
(GRS14)
PSS000984|
Multi-ancestry (including European)|
62 individuals
PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
Reported Trait: Bilateral Nucleus acumbens stress induced reward prediciton error change : 0.065 PCs(1-2)
PPM001973 PGS000767
(GRS14)
PSS000985|
Multi-ancestry (including European)|
63 individuals
PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
Reported Trait: Bilateral putamen stress induced reward prediciton error change : 0.074 PCs(1-2)
PPM001974 PGS000767
(GRS14)
PSS000986|
Multi-ancestry (including European)|
73 individuals
PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
Reported Trait: Bilateral nucleus acumbens volume : 0.064 PCs(1-2)
PPM001975 PGS000767
(GRS14)
PSS000986|
Multi-ancestry (including European)|
73 individuals
PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
Reported Trait: Bilateral putamen volume : 0.095 PCs(1-2)
PPM002022 PGS000779
(PGS7_AD)
PSS001005|
East Asian Ancestry|
112 individuals
PGP000183 |
Zhou X et al. Alzheimers Dement (Amst) (2020)
Reported Trait: Alzheimer's disease AUROC: 0.612 Beta (β, top 33.3% vs bottom 33.3%): 1.485 (0.602) Age, sex
PPM002023 PGS000779
(PGS7_AD)
PSS001006|
European Ancestry|
2,696 individuals
PGP000183 |
Zhou X et al. Alzheimers Dement (Amst) (2020)
Reported Trait: Alzheimer's disease AUROC: 0.717 Beta (β, top 33.3% vs bottom 33.3%): 2.283 (1.021) Age, sex, PCs(1-5)
PPM002140 PGS000811
(AD-PRS_39)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia in APOE ɛ4 non-carriers HR: 1.22 [1.1, 1.35] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002143 PGS000811
(AD-PRS_39)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia in APOE ɛ4 non-carriers aged between 70 and 94 HR: 1.16 [1.01, 1.34] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002144 PGS000811
(AD-PRS_39)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia in APOE ɛ4 non-carriers aged 95 years or above HR: 1.28 [1.1, 1.5] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002145 PGS000811
(AD-PRS_39)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia in APOE ɛ4 carriers aged 95 years or above HR: 0.62 [0.41, 0.95] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002141 PGS000812
(AD-PRS_57)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia HR: 1.09 [1.01, 1.19] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002142 PGS000812
(AD-PRS_57)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia in APOE ɛ4 non-carriers HR: 1.15 [1.05, 1.27] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002146 PGS000812
(AD-PRS_57)
PSS001052|
European Ancestry|
2,052 individuals
PGP000196 |
Najar J et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Incident dementia in individuals aged 95 or above HR: 1.15 [1.01, 1.32] Age at blood sampling, birth year, sex, PCs(1-10)
PPM002216 PGS000823
(GRS23_AD)
PSS001080|
European Ancestry|
12,255 individuals
PGP000207 |
van der Lee SJ et al. Lancet Neurol (2018)
Reported Trait: Incident dementia at age 85 in individuals homozygous for APOE ε4 Cumulative risk p-value (top 33.3% vs bottom 33.3%): 0.00022 Mortality
PPM002218 PGS000823
(GRS23_AD)
PSS001080|
European Ancestry|
12,255 individuals
PGP000207 |
van der Lee SJ et al. Lancet Neurol (2018)
Reported Trait: Incident dementia at age 90 Cumulative risk p-value (top 33.3% vs bottom 33.3%): 5.20e-13 Mortality
PPM002219 PGS000823
(GRS23_AD)
PSS001081|
European Ancestry|
12,978 individuals
PGP000208 |
Riaz M et al. Aging Cell (2021)
|Ext.
Reported Trait: Incident all-cause dementia Hazard Ratio (HR, top 33.3% vs bottom 33.3%): 1.36 [1.04, 1.76] Age at enrolment, sex
PPM002220 PGS000823
(GRS23_AD)
PSS001081|
European Ancestry|
12,978 individuals
PGP000208 |
Riaz M et al. Aging Cell (2021)
|Ext.
Reported Trait: Incident all-cause dementia Hazard Ratio (HR, top 33.3% vs bottom 33.3%): 1.36 [1.04, 1.77] Age at enrolment, sex, competing risk of death
PPM002215 PGS000823
(GRS23_AD)
PSS001080|
European Ancestry|
12,255 individuals
PGP000207 |
van der Lee SJ et al. Lancet Neurol (2018)
Reported Trait: Incident Alzheimer's disease at age 80 in individuals homozygous for APOE ε4 Cumulative risk p-value (top 33.3% vs bottom 33.3%): 0.0056 Non-Alzheimer's disease dementia, mortality
PPM002217 PGS000823
(GRS23_AD)
PSS001080|
European Ancestry|
12,255 individuals
PGP000207 |
van der Lee SJ et al. Lancet Neurol (2018)
Reported Trait: Incident Alzheimer's disease at age 85 Cumulative risk p-value (top 33.3% vs bottom 33.3%): 7.90e-14 Non-Alzheimer's disease dementia, mortality
PPM002214 PGS000823
(GRS23_AD)
PSS001080|
European Ancestry|
12,255 individuals
PGP000207 |
van der Lee SJ et al. Lancet Neurol (2018)
Reported Trait: Incident Alzheimer's disease at age 85 in individuals homozygous for APOE ε4 Cumulative risk p-value (top 33.3% vs bottom 33.3%): 0.0085 Non-Alzheimer's disease dementia, mortality
PPM002505 PGS000876
(PRS31_AD)
PSS001127|
European Ancestry|
8,415 individuals
PGP000222 |
Leonenko G et al. Ann Clin Transl Neurol (2019)
Reported Trait: Age at Alzheimer's disease onset β: 0.13 (0.02) Gender, PCs (1-3), APOE(ε2 + ε4) Due to SNP availability issues in the dataset, only 25 out of the 31 variants used to construct the polygenic risk score were used.
PPM002506 PGS000876
(PRS31_AD)
PSS001125|
European Ancestry|
9,903 individuals
PGP000222 |
Leonenko G et al. Ann Clin Transl Neurol (2019)
Reported Trait: Age at Alzheimer's disease onset β: 0.28 (0.04) Gender, PCs (1-3), APOE ε2, APOE ε4
PPM002507 PGS000876
(PRS31_AD)
PSS001126|
European Ancestry|
4,100 individuals
PGP000222 |
Leonenko G et al. Ann Clin Transl Neurol (2019)
Reported Trait: Age at Alzheimer's disease onset in individuals above the age of 55 β: 0.29 (0.03) Gender, PCs (1-3), APOE ε2, APOE ε4
PPM002634 PGS000898
(PRS39_AD)
PSS001167|
European Ancestry|
2,394 individuals
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Reported Trait: Alzheimer's disease (clinically confirmed) OR: 1.3 [1.18, 1.44] PCs(1-4)
PPM002635 PGS000898
(PRS39_AD)
PSS001167|
European Ancestry|
2,394 individuals
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Reported Trait: Alzheimer's disease (pathologically confirmed) OR: 1.38 [1.21, 1.58] PCs(1-4)
PPM002636 PGS000898
(PRS39_AD)
PSS001167|
European Ancestry|
2,394 individuals
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Reported Trait: Alzheimer's disease (pathologically confirmed, males) OR: 1.33 [1.13, 1.56] PCs(1-4)
PPM002637 PGS000898
(PRS39_AD)
PSS001167|
European Ancestry|
2,394 individuals
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Reported Trait: Alzheimer's disease (pathologically confirmed, females) OR: 1.32 [1.19, 1.47] PCs(1-4)
PPM002638 PGS000898
(PRS39_AD)
PSS001167|
European Ancestry|
2,394 individuals
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Reported Trait: Early-onset Alzheimer's disease (< 65 years) OR: 1.58 [1.22, 2.05] PCs(1-4)
PPM002639 PGS000898
(PRS39_AD)
PSS001167|
European Ancestry|
2,394 individuals
PGP000231 |
de Rojas I et al. Nat Commun (2021)
Reported Trait: Late-onset Alzheimer's disease (> 85 years) OR: 1.29 [1.1, 1.51] PCs(1-4)
PPM002681 PGS000907
(PRS_MDD)
PSS001279|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Escitalopram takers OR: 1.0 [0.92, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002682 PGS000907
(PRS_MDD)
PSS001284|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Venlafaxine takers OR: 1.05 [0.96, 1.15] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002684 PGS000907
(PRS_MDD)
PSS001281|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Mirtazapine takers OR: 1.05 [0.91, 1.22] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002685 PGS000907
(PRS_MDD)
PSS001277|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Desvenlafaxine takers OR: 1.01 [0.91, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002686 PGS000907
(PRS_MDD)
PSS001276|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Citalopram takers OR: 1.02 [0.9, 1.16] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002687 PGS000907
(PRS_MDD)
PSS001280|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Fluoxetine takers OR: 1.06 [0.96, 1.17] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002688 PGS000907
(PRS_MDD)
PSS001278|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Duloxetine takers OR: 1.06 [0.95, 1.2] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002689 PGS000907
(PRS_MDD)
PSS001282|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Paroxetine takers OR: 1.08 [0.92, 1.26] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002690 PGS000907
(PRS_MDD)
PSS001243|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Sertraline takers OR: 1.06 [0.98, 1.14] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002691 PGS000907
(PRS_MDD)
PSS001239|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Escitalopram takers OR: 1.06 [0.98, 1.15] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002692 PGS000907
(PRS_MDD)
PSS001244|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Venlafaxine takers OR: 1.01 [0.93, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002693 PGS000907
(PRS_MDD)
PSS001235|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Amitriptyline takers OR: 0.96 [0.83, 1.1] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002694 PGS000907
(PRS_MDD)
PSS001241|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Mirtazapine takers OR: 1.07 [0.93, 1.23] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002695 PGS000907
(PRS_MDD)
PSS001237|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Desvenlafaxine takers OR: 0.97 [0.87, 1.07] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002696 PGS000907
(PRS_MDD)
PSS001236|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Citalopram takers OR: 0.99 [0.87, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002697 PGS000907
(PRS_MDD)
PSS001240|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Fluoxetine takers OR: 1.16 [1.04, 1.29] Variance explained (Nagelkerke's R2*100): 0.41 sex, age at study enrollment, genetic PCs 1-20
PPM002698 PGS000907
(PRS_MDD)
PSS001238|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Duloxetine takers OR: 0.98 [0.88, 1.1] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002699 PGS000907
(PRS_MDD)
PSS001242|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dizziness in Paroxetine takers OR: 1.08 [0.93, 1.24] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002700 PGS000907
(PRS_MDD)
PSS001373|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Sertraline takers OR: 1.03 [0.94, 1.12] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002701 PGS000907
(PRS_MDD)
PSS001369|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Escitalopram takers OR: 1.01 [0.9, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002702 PGS000907
(PRS_MDD)
PSS001374|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Venlafaxine takers OR: 1.1 [1.0, 1.22] Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20
PPM002703 PGS000907
(PRS_MDD)
PSS001365|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Amitriptyline takers OR: 0.99 [0.81, 1.2] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002704 PGS000907
(PRS_MDD)
PSS001371|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Mirtazapine takers OR: 1.03 [0.86, 1.24] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002705 PGS000907
(PRS_MDD)
PSS001367|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Desvenlafaxine takers OR: 1.04 [0.92, 1.18] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002707 PGS000907
(PRS_MDD)
PSS001370|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Fluoxetine takers OR: 1.06 [0.95, 1.19] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002708 PGS000907
(PRS_MDD)
PSS001368|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Duloxetine takers OR: 0.9 [0.79, 1.04] Variance explained (Nagelkerke's R2*100): 0.21 sex, age at study enrollment, genetic PCs 1-20
PPM002709 PGS000907
(PRS_MDD)
PSS001372|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Paroxetine takers OR: 1.19 [1.0, 1.41] Variance explained (Nagelkerke's R2*100): 0.53 sex, age at study enrollment, genetic PCs 1-20
PPM002710 PGS000907
(PRS_MDD)
PSS001303|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Sertraline takers OR: 1.13 [0.97, 1.31] Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20
PPM002711 PGS000907
(PRS_MDD)
PSS001299|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Escitalopram takers OR: 0.96 [0.8, 1.14] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002712 PGS000907
(PRS_MDD)
PSS001304|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Venlafaxine takers OR: 1.22 [1.03, 1.45] Variance explained (Nagelkerke's R2*100): 0.51 sex, age at study enrollment, genetic PCs 1-20
PPM002713 PGS000907
(PRS_MDD)
PSS001295|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Amitriptyline takers OR: 1.06 [0.8, 1.4] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002715 PGS000907
(PRS_MDD)
PSS001297|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Desvenlafaxine takers OR: 1.0 [0.8, 1.24] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002716 PGS000907
(PRS_MDD)
PSS001296|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Citalopram takers OR: 0.95 [0.72, 1.27] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002717 PGS000907
(PRS_MDD)
PSS001300|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Fluoxetine takers OR: 1.3 [1.05, 1.6] Variance explained (Nagelkerke's R2*100): 0.77 sex, age at study enrollment, genetic PCs 1-20
PPM002718 PGS000907
(PRS_MDD)
PSS001298|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Duloxetine takers OR: 0.99 [0.82, 1.2] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002720 PGS000907
(PRS_MDD)
PSS001263|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Sertraline takers OR: 1.04 [0.98, 1.11] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002721 PGS000907
(PRS_MDD)
PSS001259|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Escitalopram takers OR: 1.01 [0.94, 1.09] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002722 PGS000907
(PRS_MDD)
PSS001264|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Venlafaxine takers OR: 0.98 [0.91, 1.05] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002723 PGS000907
(PRS_MDD)
PSS001255|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Amitriptyline takers OR: 1.06 [0.95, 1.17] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002724 PGS000907
(PRS_MDD)
PSS001261|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Mirtazapine takers OR: 1.05 [0.94, 1.17] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002725 PGS000907
(PRS_MDD)
PSS001257|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Desvenlafaxine takers OR: 1.09 [0.99, 1.2] Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20
PPM002726 PGS000907
(PRS_MDD)
PSS001256|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Citalopram takers OR: 1.11 [1.0, 1.23] Variance explained (Nagelkerke's R2*100): 0.23 sex, age at study enrollment, genetic PCs 1-20
PPM002727 PGS000907
(PRS_MDD)
PSS001260|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Fluoxetine takers OR: 1.0 [0.92, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002728 PGS000907
(PRS_MDD)
PSS001258|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Duloxetine takers OR: 1.03 [0.93, 1.13] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002729 PGS000907
(PRS_MDD)
PSS001262|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Dry mouth in Paroxetine takers OR: 0.98 [0.86, 1.1] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002730 PGS000907
(PRS_MDD)
PSS001403|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Sertraline takers OR: 0.99 [0.92, 1.07] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002731 PGS000907
(PRS_MDD)
PSS001399|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Escitalopram takers OR: 0.97 [0.89, 1.06] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002732 PGS000907
(PRS_MDD)
PSS001404|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Venlafaxine takers OR: 1.04 [0.96, 1.12] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002733 PGS000907
(PRS_MDD)
PSS001395|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Amitriptyline takers OR: 1.14 [0.96, 1.37] Variance explained (Nagelkerke's R2*100): 0.3 sex, age at study enrollment, genetic PCs 1-20
PPM002734 PGS000907
(PRS_MDD)
PSS001401|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Mirtazapine takers OR: 1.05 [0.9, 1.22] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002735 PGS000907
(PRS_MDD)
PSS001397|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Desvenlafaxine takers OR: 0.99 [0.9, 1.1] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002736 PGS000907
(PRS_MDD)
PSS001396|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Citalopram takers OR: 1.14 [0.99, 1.3] Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20
PPM002737 PGS000907
(PRS_MDD)
PSS001400|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Fluoxetine takers OR: 1.04 [0.94, 1.16] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002738 PGS000907
(PRS_MDD)
PSS001398|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Duloxetine takers OR: 0.96 [0.86, 1.07] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002739 PGS000907
(PRS_MDD)
PSS001402|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Sweating in Paroxetine takers OR: 1.1 [0.94, 1.28] Variance explained (Nagelkerke's R2*100): 0.17 sex, age at study enrollment, genetic PCs 1-20
PPM002741 PGS000907
(PRS_MDD)
PSS001309|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Escitalopram takers OR: 1.06 [0.98, 1.15] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002742 PGS000907
(PRS_MDD)
PSS001314|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Venlafaxine takers OR: 1.08 [1.0, 1.17] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002743 PGS000907
(PRS_MDD)
PSS001305|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Amitriptyline takers OR: 1.12 [0.95, 1.31] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002744 PGS000907
(PRS_MDD)
PSS001311|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Mirtazapine takers OR: 1.08 [0.93, 1.25] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002745 PGS000907
(PRS_MDD)
PSS001307|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Desvenlafaxine takers OR: 1.06 [0.96, 1.17] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002746 PGS000907
(PRS_MDD)
PSS001306|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Citalopram takers OR: 1.11 [0.99, 1.25] Variance explained (Nagelkerke's R2*100): 0.24 sex, age at study enrollment, genetic PCs 1-20
PPM002747 PGS000907
(PRS_MDD)
PSS001310|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Fluoxetine takers OR: 1.06 [0.97, 1.16] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002748 PGS000907
(PRS_MDD)
PSS001308|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Duloxetine takers OR: 1.16 [1.04, 1.29] Variance explained (Nagelkerke's R2*100): 0.55 sex, age at study enrollment, genetic PCs 1-20
PPM002749 PGS000907
(PRS_MDD)
PSS001312|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Paroxetine takers OR: 1.1 [0.96, 1.27] Variance explained (Nagelkerke's R2*100): 0.21 sex, age at study enrollment, genetic PCs 1-20
PPM002750 PGS000907
(PRS_MDD)
PSS001423|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Sertraline takers OR: 1.21 [1.03, 1.43] Variance explained (Nagelkerke's R2*100): 0.44 sex, age at study enrollment, genetic PCs 1-20
PPM002751 PGS000907
(PRS_MDD)
PSS001419|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Escitalopram takers OR: 0.96 [0.78, 1.18] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002752 PGS000907
(PRS_MDD)
PSS001424|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Venlafaxine takers OR: 1.14 [0.96, 1.36] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002754 PGS000907
(PRS_MDD)
PSS001421|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Mirtazapine takers OR: 1.23 [0.88, 1.72] Variance explained (Nagelkerke's R2*100): 0.45 sex, age at study enrollment, genetic PCs 1-20
PPM002755 PGS000907
(PRS_MDD)
PSS001417|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Desvenlafaxine takers OR: 1.08 [0.86, 1.36] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002756 PGS000907
(PRS_MDD)
PSS001416|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Citalopram takers OR: 1.19 [0.87, 1.64] Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20
PPM002757 PGS000907
(PRS_MDD)
PSS001420|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Fluoxetine takers OR: 1.01 [0.8, 1.28] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002758 PGS000907
(PRS_MDD)
PSS001418|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Duloxetine takers OR: 1.09 [0.87, 1.35] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002759 PGS000907
(PRS_MDD)
PSS001422|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Paroxetine takers OR: 1.17 [0.86, 1.61] Variance explained (Nagelkerke's R2*100): 0.3 sex, age at study enrollment, genetic PCs 1-20
PPM002760 PGS000907
(PRS_MDD)
PSS001223|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Sertraline takers OR: 1.15 [1.03, 1.29] Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20
PPM002761 PGS000907
(PRS_MDD)
PSS001219|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Escitalopram takers OR: 1.16 [1.01, 1.33] Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20
PPM002762 PGS000907
(PRS_MDD)
PSS001224|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Venlafaxine takers OR: 1.19 [1.07, 1.34] Variance explained (Nagelkerke's R2*100): 0.54 sex, age at study enrollment, genetic PCs 1-20
PPM002763 PGS000907
(PRS_MDD)
PSS001215|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Amitriptyline takers OR: 1.16 [0.98, 1.37] Variance explained (Nagelkerke's R2*100): 0.38 sex, age at study enrollment, genetic PCs 1-20
PPM002764 PGS000907
(PRS_MDD)
PSS001221|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Mirtazapine takers OR: 1.08 [0.89, 1.29] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002765 PGS000907
(PRS_MDD)
PSS001217|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Desvenlafaxine takers OR: 1.03 [0.89, 1.2] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002767 PGS000907
(PRS_MDD)
PSS001220|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Fluoxetine takers OR: 1.09 [0.94, 1.27] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002768 PGS000907
(PRS_MDD)
PSS001218|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Duloxetine takers OR: 1.02 [0.89, 1.18] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002769 PGS000907
(PRS_MDD)
PSS001222|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Paroxetine takers OR: 1.09 [0.9, 1.31] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002771 PGS000907
(PRS_MDD)
PSS001229|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Escitalopram takers OR: 1.01 [0.89, 1.16] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002772 PGS000907
(PRS_MDD)
PSS001234|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Venlafaxine takers OR: 1.13 [0.97, 1.32] Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20
PPM002773 PGS000907
(PRS_MDD)
PSS001225|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Amitriptyline takers OR: 1.02 [0.73, 1.42] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002774 PGS000907
(PRS_MDD)
PSS001231|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Mirtazapine takers OR: 1.13 [0.89, 1.42] Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20
PPM002775 PGS000907
(PRS_MDD)
PSS001227|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Desvenlafaxine takers OR: 1.01 [0.84, 1.21] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002776 PGS000907
(PRS_MDD)
PSS001226|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Citalopram takers OR: 0.95 [0.76, 1.19] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002777 PGS000907
(PRS_MDD)
PSS001230|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Fluoxetine takers OR: 0.99 [0.84, 1.17] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002778 PGS000907
(PRS_MDD)
PSS001228|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Duloxetine takers OR: 1.08 [0.9, 1.3] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002779 PGS000907
(PRS_MDD)
PSS001232|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Paroxetine takers OR: 1.47 [1.13, 1.91] Variance explained (Nagelkerke's R2*100): 1.92 sex, age at study enrollment, genetic PCs 1-20
PPM002780 PGS000907
(PRS_MDD)
PSS001253|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Sertraline takers OR: 1.01 [0.94, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002782 PGS000907
(PRS_MDD)
PSS001254|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Venlafaxine takers OR: 1.0 [0.91, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002783 PGS000907
(PRS_MDD)
PSS001245|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Amitriptyline takers OR: 0.99 [0.89, 1.11] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002784 PGS000907
(PRS_MDD)
PSS001251|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Mirtazapine takers OR: 1.06 [0.96, 1.18] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002785 PGS000907
(PRS_MDD)
PSS001247|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Desvenlafaxine takers OR: 0.99 [0.88, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002786 PGS000907
(PRS_MDD)
PSS001246|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Citalopram takers OR: 1.05 [0.93, 1.18] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002787 PGS000907
(PRS_MDD)
PSS001250|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Fluoxetine takers OR: 1.04 [0.94, 1.14] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002788 PGS000907
(PRS_MDD)
PSS001248|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Duloxetine takers OR: 0.96 [0.86, 1.08] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002789 PGS000907
(PRS_MDD)
PSS001252|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Paroxetine takers OR: 0.97 [0.83, 1.12] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002790 PGS000907
(PRS_MDD)
PSS001413|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Sertraline takers OR: 1.04 [0.97, 1.12] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002791 PGS000907
(PRS_MDD)
PSS001409|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Escitalopram takers OR: 1.02 [0.94, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002792 PGS000907
(PRS_MDD)
PSS001414|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Venlafaxine takers OR: 1.02 [0.94, 1.1] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002793 PGS000907
(PRS_MDD)
PSS001405|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Amitriptyline takers OR: 1.05 [0.88, 1.26] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002794 PGS000907
(PRS_MDD)
PSS001411|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Mirtazapine takers OR: 1.13 [0.97, 1.32] Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20
PPM002795 PGS000907
(PRS_MDD)
PSS001407|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Desvenlafaxine takers OR: 1.05 [0.95, 1.16] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002796 PGS000907
(PRS_MDD)
PSS001406|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Citalopram takers OR: 1.0 [0.89, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002797 PGS000907
(PRS_MDD)
PSS001410|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Fluoxetine takers OR: 1.05 [0.96, 1.15] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002798 PGS000907
(PRS_MDD)
PSS001408|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Duloxetine takers OR: 0.97 [0.87, 1.09] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002800 PGS000907
(PRS_MDD)
PSS001203|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Sertraline takers OR: 1.13 [1.04, 1.22] Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20
PPM002801 PGS000907
(PRS_MDD)
PSS001199|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Escitalopram takers OR: 1.01 [0.91, 1.11] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002802 PGS000907
(PRS_MDD)
PSS001204|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Venlafaxine takers OR: 1.14 [1.04, 1.26] Variance explained (Nagelkerke's R2*100): 0.36 sex, age at study enrollment, genetic PCs 1-20
PPM002803 PGS000907
(PRS_MDD)
PSS001195|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Amitriptyline takers OR: 1.05 [0.87, 1.27] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002804 PGS000907
(PRS_MDD)
PSS001201|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Mirtazapine takers OR: 1.2 [1.03, 1.39] Variance explained (Nagelkerke's R2*100): 0.59 sex, age at study enrollment, genetic PCs 1-20
PPM002805 PGS000907
(PRS_MDD)
PSS001197|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Desvenlafaxine takers OR: 1.04 [0.92, 1.17] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002806 PGS000907
(PRS_MDD)
PSS001196|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Citalopram takers OR: 0.97 [0.85, 1.12] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002807 PGS000907
(PRS_MDD)
PSS001200|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Fluoxetine takers OR: 1.05 [0.96, 1.16] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002808 PGS000907
(PRS_MDD)
PSS001198|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Duloxetine takers OR: 1.0 [0.87, 1.14] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002809 PGS000907
(PRS_MDD)
PSS001202|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Anxiety in Paroxetine takers OR: 1.1 [0.94, 1.29] Variance explained (Nagelkerke's R2*100): 0.19 sex, age at study enrollment, genetic PCs 1-20
PPM002810 PGS000907
(PRS_MDD)
PSS001193|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Sertraline takers OR: 1.04 [0.96, 1.13] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002811 PGS000907
(PRS_MDD)
PSS001189|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Escitalopram takers OR: 1.06 [0.96, 1.17] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002812 PGS000907
(PRS_MDD)
PSS001194|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Venlafaxine takers OR: 1.06 [0.97, 1.17] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002813 PGS000907
(PRS_MDD)
PSS001185|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Amitriptyline takers OR: 1.02 [0.85, 1.23] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002814 PGS000907
(PRS_MDD)
PSS001191|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Mirtazapine takers OR: 1.25 [1.08, 1.46] Variance explained (Nagelkerke's R2*100): 0.93 sex, age at study enrollment, genetic PCs 1-20
PPM002816 PGS000907
(PRS_MDD)
PSS001186|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Citalopram takers OR: 1.05 [0.91, 1.21] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002817 PGS000907
(PRS_MDD)
PSS001190|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Fluoxetine takers OR: 1.06 [0.96, 1.18] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002818 PGS000907
(PRS_MDD)
PSS001188|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Duloxetine takers OR: 1.05 [0.91, 1.21] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002819 PGS000907
(PRS_MDD)
PSS001192|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Paroxetine takers OR: 1.19 [1.02, 1.38] Variance explained (Nagelkerke's R2*100): 0.6 sex, age at study enrollment, genetic PCs 1-20
PPM002820 PGS000907
(PRS_MDD)
PSS001273|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Sertraline takers OR: 1.01 [0.94, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002821 PGS000907
(PRS_MDD)
PSS001269|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Escitalopram takers OR: 0.96 [0.88, 1.05] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002822 PGS000907
(PRS_MDD)
PSS001274|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Venlafaxine takers OR: 1.06 [0.97, 1.16] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002823 PGS000907
(PRS_MDD)
PSS001265|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Amitriptyline takers OR: 1.12 [0.97, 1.28] Variance explained (Nagelkerke's R2*100): 0.25 sex, age at study enrollment, genetic PCs 1-20
PPM002824 PGS000907
(PRS_MDD)
PSS001271|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Mirtazapine takers OR: 1.06 [0.94, 1.2] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002826 PGS000907
(PRS_MDD)
PSS001266|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Citalopram takers OR: 0.98 [0.86, 1.11] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002827 PGS000907
(PRS_MDD)
PSS001270|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Fluoxetine takers OR: 1.02 [0.92, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002829 PGS000907
(PRS_MDD)
PSS001272|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Paroxetine takers OR: 0.96 [0.82, 1.11] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002831 PGS000907
(PRS_MDD)
PSS001429|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Escitalopram takers OR: 1.04 [0.97, 1.11] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002832 PGS000907
(PRS_MDD)
PSS001434|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Venlafaxine takers OR: 1.03 [0.96, 1.11] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002833 PGS000907
(PRS_MDD)
PSS001425|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Amitriptyline takers OR: 1.06 [0.95, 1.19] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002834 PGS000907
(PRS_MDD)
PSS001431|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Mirtazapine takers OR: 1.02 [0.93, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002835 PGS000907
(PRS_MDD)
PSS001427|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Desvenlafaxine takers OR: 1.11 [1.02, 1.22] Variance explained (Nagelkerke's R2*100): 0.33 sex, age at study enrollment, genetic PCs 1-20
PPM002836 PGS000907
(PRS_MDD)
PSS001426|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Citalopram takers OR: 1.14 [1.03, 1.25] Variance explained (Nagelkerke's R2*100): 0.4 sex, age at study enrollment, genetic PCs 1-20
PPM002837 PGS000907
(PRS_MDD)
PSS001430|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Fluoxetine takers OR: 1.04 [0.96, 1.12] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002838 PGS000907
(PRS_MDD)
PSS001428|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Duloxetine takers OR: 1.0 [0.91, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002839 PGS000907
(PRS_MDD)
PSS001432|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Paroxetine takers OR: 1.11 [0.99, 1.24] Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20
PPM002840 PGS000907
(PRS_MDD)
PSS001443|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Sertraline takers OR: 0.9 [0.75, 1.07] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002841 PGS000907
(PRS_MDD)
PSS001439|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Escitalopram takers OR: 1.07 [0.88, 1.32] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002842 PGS000907
(PRS_MDD)
PSS001444|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Venlafaxine takers OR: 1.05 [0.84, 1.3] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002844 PGS000907
(PRS_MDD)
PSS001441|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Mirtazapine takers OR: 1.21 [0.85, 1.71] Variance explained (Nagelkerke's R2*100): 0.37 sex, age at study enrollment, genetic PCs 1-20
PPM002845 PGS000907
(PRS_MDD)
PSS001437|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Desvenlafaxine takers OR: 0.95 [0.74, 1.22] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002846 PGS000907
(PRS_MDD)
PSS001436|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Citalopram takers OR: 0.87 [0.61, 1.23] Variance explained (Nagelkerke's R2*100): 0.19 sex, age at study enrollment, genetic PCs 1-20
PPM002847 PGS000907
(PRS_MDD)
PSS001440|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Fluoxetine takers OR: 1.16 [0.96, 1.39] Variance explained (Nagelkerke's R2*100): 0.26 sex, age at study enrollment, genetic PCs 1-20
PPM002848 PGS000907
(PRS_MDD)
PSS001438|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Duloxetine takers OR: 0.96 [0.75, 1.23] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002849 PGS000907
(PRS_MDD)
PSS001442|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Paroxetine takers OR: 1.36 [0.88, 2.1] Variance explained (Nagelkerke's R2*100): 0.99 sex, age at study enrollment, genetic PCs 1-20
PPM002852 PGS000907
(PRS_MDD)
PSS001344|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Venlafaxine takers OR: 1.0 [0.74, 1.36] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002853 PGS000907
(PRS_MDD)
PSS001335|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Amitriptyline takers OR: 1.22 [0.73, 2.04] Variance explained (Nagelkerke's R2*100): 0.42 sex, age at study enrollment, genetic PCs 1-20
PPM002854 PGS000907
(PRS_MDD)
PSS001341|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Mirtazapine takers OR: 1.0 [0.65, 1.52] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002855 PGS000907
(PRS_MDD)
PSS001337|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Desvenlafaxine takers OR: 1.58 [1.13, 2.23] Variance explained (Nagelkerke's R2*100): 2.19 sex, age at study enrollment, genetic PCs 1-20
PPM002856 PGS000907
(PRS_MDD)
PSS001336|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Citalopram takers OR: 1.1 [0.7, 1.74] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002857 PGS000907
(PRS_MDD)
PSS001340|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Fluoxetine takers OR: 1.34 [0.91, 1.97] Variance explained (Nagelkerke's R2*100): 0.75 sex, age at study enrollment, genetic PCs 1-20
PPM002858 PGS000907
(PRS_MDD)
PSS001338|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Duloxetine takers OR: 1.13 [0.75, 1.7] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002859 PGS000907
(PRS_MDD)
PSS001342|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Paroxetine takers OR: 1.16 [0.69, 1.95] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002860 PGS000907
(PRS_MDD)
PSS001363|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Sertraline takers OR: 1.0 [0.79, 1.28] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002861 PGS000907
(PRS_MDD)
PSS001359|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Escitalopram takers OR: 0.91 [0.69, 1.19] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002862 PGS000907
(PRS_MDD)
PSS001364|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Venlafaxine takers OR: 1.06 [0.8, 1.42] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002863 PGS000907
(PRS_MDD)
PSS001355|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Amitriptyline takers OR: 0.59 [0.36, 0.98] Variance explained (Nagelkerke's R2*100): 2.43 sex, age at study enrollment, genetic PCs 1-20
PPM002864 PGS000907
(PRS_MDD)
PSS001361|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Mirtazapine takers OR: 0.85 [0.55, 1.3] Variance explained (Nagelkerke's R2*100): 0.25 sex, age at study enrollment, genetic PCs 1-20
PPM002865 PGS000907
(PRS_MDD)
PSS001357|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Desvenlafaxine takers OR: 0.8 [0.59, 1.07] Variance explained (Nagelkerke's R2*100): 0.58 sex, age at study enrollment, genetic PCs 1-20
PPM002868 PGS000907
(PRS_MDD)
PSS001358|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Duloxetine takers OR: 0.99 [0.71, 1.38] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002869 PGS000907
(PRS_MDD)
PSS001362|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Paroxetine takers OR: 0.9 [0.53, 1.52] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002870 PGS000907
(PRS_MDD)
PSS001353|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Sertraline takers OR: 1.0 [0.95, 1.06] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002871 PGS000907
(PRS_MDD)
PSS001349|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Escitalopram takers OR: 0.99 [0.93, 1.06] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002872 PGS000907
(PRS_MDD)
PSS001354|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Venlafaxine takers OR: 1.05 [0.99, 1.13] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002873 PGS000907
(PRS_MDD)
PSS001345|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Amitriptyline takers OR: 1.08 [0.96, 1.22] Variance explained (Nagelkerke's R2*100): 0.16 sex, age at study enrollment, genetic PCs 1-20
PPM002878 PGS000907
(PRS_MDD)
PSS001348|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Duloxetine takers OR: 0.99 [0.91, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002879 PGS000907
(PRS_MDD)
PSS001352|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Paroxetine takers OR: 1.0 [0.9, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002883 PGS000907
(PRS_MDD)
PSS001205|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Amitriptyline takers OR: 1.08 [0.86, 1.36] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002884 PGS000907
(PRS_MDD)
PSS001211|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Mirtazapine takers OR: 1.05 [0.84, 1.31] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002885 PGS000907
(PRS_MDD)
PSS001207|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Desvenlafaxine takers OR: 1.13 [0.94, 1.37] Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20
PPM002886 PGS000907
(PRS_MDD)
PSS001206|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Citalopram takers OR: 1.39 [1.08, 1.79] Variance explained (Nagelkerke's R2*100): 1.2 sex, age at study enrollment, genetic PCs 1-20
PPM002887 PGS000907
(PRS_MDD)
PSS001210|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Fluoxetine takers OR: 1.03 [0.85, 1.24] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002888 PGS000907
(PRS_MDD)
PSS001208|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Duloxetine takers OR: 1.04 [0.87, 1.26] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002889 PGS000907
(PRS_MDD)
PSS001212|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Paroxetine takers OR: 1.32 [1.0, 1.75] Variance explained (Nagelkerke's R2*100): 0.99 sex, age at study enrollment, genetic PCs 1-20
PPM002890 PGS000907
(PRS_MDD)
PSS001393|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Sertraline takers OR: 1.24 [1.14, 1.34] Variance explained (Nagelkerke's R2*100): 0.9 sex, age at study enrollment, genetic PCs 1-20
PPM002894 PGS000907
(PRS_MDD)
PSS001391|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Mirtazapine takers OR: 1.09 [0.94, 1.25] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002895 PGS000907
(PRS_MDD)
PSS001387|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Desvenlafaxine takers OR: 1.06 [0.94, 1.2] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002896 PGS000907
(PRS_MDD)
PSS001386|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Citalopram takers OR: 1.06 [0.92, 1.22] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002897 PGS000907
(PRS_MDD)
PSS001390|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Fluoxetine takers OR: 1.12 [1.02, 1.23] Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20
PPM002898 PGS000907
(PRS_MDD)
PSS001388|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Duloxetine takers OR: 0.98 [0.86, 1.12] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002899 PGS000907
(PRS_MDD)
PSS001392|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Paroxetine takers OR: 1.22 [1.05, 1.42] Variance explained (Nagelkerke's R2*100): 0.8 sex, age at study enrollment, genetic PCs 1-20
PPM002900 PGS000907
(PRS_MDD)
PSS001383|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Sertraline takers OR: 1.15 [1.01, 1.31] Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20
PPM002901 PGS000907
(PRS_MDD)
PSS001379|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Escitalopram takers OR: 1.06 [0.9, 1.24] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002902 PGS000907
(PRS_MDD)
PSS001384|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Venlafaxine takers OR: 1.36 [1.18, 1.58] Variance explained (Nagelkerke's R2*100): 1.35 sex, age at study enrollment, genetic PCs 1-20
PPM002903 PGS000907
(PRS_MDD)
PSS001375|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Amitriptyline takers OR: 0.97 [0.75, 1.24] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002904 PGS000907
(PRS_MDD)
PSS001381|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Mirtazapine takers OR: 1.11 [0.88, 1.4] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002905 PGS000907
(PRS_MDD)
PSS001377|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Desvenlafaxine takers OR: 0.97 [0.78, 1.21] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002906 PGS000907
(PRS_MDD)
PSS001376|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Citalopram takers OR: 0.96 [0.76, 1.21] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002907 PGS000907
(PRS_MDD)
PSS001380|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Fluoxetine takers OR: 1.09 [0.95, 1.26] Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20
PPM002908 PGS000907
(PRS_MDD)
PSS001378|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Duloxetine takers OR: 1.11 [0.89, 1.38] Variance explained (Nagelkerke's R2*100): 0.15 sex, age at study enrollment, genetic PCs 1-20
PPM002909 PGS000907
(PRS_MDD)
PSS001382|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide attempt in Paroxetine takers OR: 1.22 [0.95, 1.55] Variance explained (Nagelkerke's R2*100): 0.54 sex, age at study enrollment, genetic PCs 1-20
PPM002910 PGS000907
(PRS_MDD)
PSS001333|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Sertraline takers OR: 0.99 [0.91, 1.09] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002911 PGS000907
(PRS_MDD)
PSS001329|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Escitalopram takers OR: 0.96 [0.86, 1.07] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002912 PGS000907
(PRS_MDD)
PSS001334|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Venlafaxine takers OR: 1.14 [1.03, 1.27] Variance explained (Nagelkerke's R2*100): 0.31 sex, age at study enrollment, genetic PCs 1-20
PPM002913 PGS000907
(PRS_MDD)
PSS001325|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Amitriptyline takers OR: 1.07 [0.88, 1.29] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002914 PGS000907
(PRS_MDD)
PSS001331|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Mirtazapine takers OR: 1.03 [0.87, 1.2] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002915 PGS000907
(PRS_MDD)
PSS001327|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Desvenlafaxine takers OR: 1.02 [0.88, 1.18] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002916 PGS000907
(PRS_MDD)
PSS001326|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Citalopram takers OR: 0.95 [0.82, 1.1] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002917 PGS000907
(PRS_MDD)
PSS001330|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Fluoxetine takers OR: 1.05 [0.93, 1.18] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002918 PGS000907
(PRS_MDD)
PSS001328|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Duloxetine takers OR: 1.04 [0.89, 1.2] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002919 PGS000907
(PRS_MDD)
PSS001332|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Other side effects in Paroxetine takers OR: 0.97 [0.81, 1.16] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002920 PGS000907
(PRS_MDD)
PSS001323|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Sertraline takers OR: 1.04 [0.89, 1.21] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002921 PGS000907
(PRS_MDD)
PSS001319|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Escitalopram takers OR: 1.04 [0.89, 1.22] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002922 PGS000907
(PRS_MDD)
PSS001324|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Venlafaxine takers OR: 0.94 [0.79, 1.12] Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20
PPM002923 PGS000907
(PRS_MDD)
PSS001315|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Amitriptyline takers OR: 1.03 [0.84, 1.25] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002924 PGS000907
(PRS_MDD)
PSS001321|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Mirtazapine takers OR: 1.05 [0.83, 1.33] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002925 PGS000907
(PRS_MDD)
PSS001317|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Desvenlafaxine takers OR: 0.82 [0.68, 0.98] Variance explained (Nagelkerke's R2*100): 0.6 sex, age at study enrollment, genetic PCs 1-20
PPM002680 PGS000907
(PRS_MDD)
PSS001283|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Sertraline takers OR: 1.03 [0.95, 1.11] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002683 PGS000907
(PRS_MDD)
PSS001275|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Headaches in Amitriptyline takers OR: 0.96 [0.81, 1.12] Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20
PPM002706 PGS000907
(PRS_MDD)
PSS001366|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Shakes in Citalopram takers OR: 1.16 [0.98, 1.38] Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20
PPM002714 PGS000907
(PRS_MDD)
PSS001301|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Mirtazapine takers OR: 1.13 [0.9, 1.43] Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20
PPM002719 PGS000907
(PRS_MDD)
PSS001302|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Muscle pain in Paroxetine takers OR: 1.18 [0.87, 1.61] Variance explained (Nagelkerke's R2*100): 0.34 sex, age at study enrollment, genetic PCs 1-20
PPM002740 PGS000907
(PRS_MDD)
PSS001313|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Nausea in Sertraline takers OR: 1.08 [1.01, 1.15] Variance explained (Nagelkerke's R2*100): 0.13 sex, age at study enrollment, genetic PCs 1-20
PPM002753 PGS000907
(PRS_MDD)
PSS001415|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Vomit in Amitriptyline takers OR: 0.93 [0.65, 1.33] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002766 PGS000907
(PRS_MDD)
PSS001216|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Constipation in Citalopram takers OR: 1.02 [0.85, 1.22] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002770 PGS000907
(PRS_MDD)
PSS001233|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Diarrhoea in Sertraline takers OR: 1.05 [0.94, 1.16] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002781 PGS000907
(PRS_MDD)
PSS001249|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Drowsiness in Escitalopram takers OR: 0.96 [0.89, 1.05] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002799 PGS000907
(PRS_MDD)
PSS001412|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Trouble sleeping in Paroxetine takers OR: 1.06 [0.92, 1.22] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002815 PGS000907
(PRS_MDD)
PSS001187|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Agitation in Desvenlafaxine takers OR: 1.07 [0.94, 1.21] Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20
PPM002825 PGS000907
(PRS_MDD)
PSS001267|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Desvenlafaxine takers OR: 1.02 [0.91, 1.15] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002828 PGS000907
(PRS_MDD)
PSS001268|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Fatigue in Duloxetine takers OR: 0.93 [0.83, 1.04] Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20
PPM002830 PGS000907
(PRS_MDD)
PSS001433|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight gain in Sertraline takers OR: 1.02 [0.96, 1.08] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002843 PGS000907
(PRS_MDD)
PSS001435|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Weight loss in Amitriptyline takers OR: 1.09 [0.67, 1.78] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002850 PGS000907
(PRS_MDD)
PSS001343|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Sertraline takers OR: 1.04 [0.8, 1.36] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002851 PGS000907
(PRS_MDD)
PSS001339|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Rashes in Escitalopram takers OR: 1.09 [0.79, 1.5] Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20
PPM002866 PGS000907
(PRS_MDD)
PSS001356|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Citalopram takers OR: 1.05 [0.73, 1.51] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002867 PGS000907
(PRS_MDD)
PSS001360|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Runny nose in Fluoxetine takers OR: 1.03 [0.76, 1.4] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002874 PGS000907
(PRS_MDD)
PSS001351|
European Ancestry|
1,987 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Mirtazapine takers OR: 0.99 [0.9, 1.1] Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20
PPM002875 PGS000907
(PRS_MDD)
PSS001347|
European Ancestry|
2,524 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Desvenlafaxine takers OR: 1.11 [1.02, 1.21] Variance explained (Nagelkerke's R2*100): 0.34 sex, age at study enrollment, genetic PCs 1-20
PPM002876 PGS000907
(PRS_MDD)
PSS001346|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Citalopram takers OR: 1.1 [1.01, 1.2] Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20
PPM002877 PGS000907
(PRS_MDD)
PSS001350|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Reduced sexual desire in Fluoxetine takers OR: 1.05 [0.98, 1.12] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002880 PGS000907
(PRS_MDD)
PSS001213|
European Ancestry|
5,719 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Sertraline takers OR: 0.96 [0.83, 1.11] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002881 PGS000907
(PRS_MDD)
PSS001209|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Escitalopram takers OR: 1.03 [0.87, 1.22] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002882 PGS000907
(PRS_MDD)
PSS001214|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Blurry vision in Venlafaxine takers OR: 0.97 [0.84, 1.12] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002891 PGS000907
(PRS_MDD)
PSS001389|
European Ancestry|
4,365 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Escitalopram takers OR: 1.09 [0.99, 1.2] Variance explained (Nagelkerke's R2*100): 0.15 sex, age at study enrollment, genetic PCs 1-20
PPM002892 PGS000907
(PRS_MDD)
PSS001394|
European Ancestry|
3,967 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Venlafaxine takers OR: 1.19 [1.09, 1.31] Variance explained (Nagelkerke's R2*100): 0.63 sex, age at study enrollment, genetic PCs 1-20
PPM002893 PGS000907
(PRS_MDD)
PSS001385|
European Ancestry|
1,657 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Suicide thoughts in Amitriptyline takers OR: 0.94 [0.8, 1.11] Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20
PPM002926 PGS000907
(PRS_MDD)
PSS001316|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Citalopram takers OR: 1.08 [0.92, 1.28] Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20
PPM002927 PGS000907
(PRS_MDD)
PSS001320|
European Ancestry|
3,670 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Fluoxetine takers OR: 1.05 [0.91, 1.21] Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20
PPM002928 PGS000907
(PRS_MDD)
PSS001318|
European Ancestry|
1,995 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Duloxetine takers OR: 0.91 [0.74, 1.13] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002929 PGS000907
(PRS_MDD)
PSS001322|
European Ancestry|
1,580 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: No side effects in Paroxetine takers OR: 0.97 [0.77, 1.22] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002950 PGS000908
(PRS_Insomnia)
PSS001293|
European Ancestry|
5,713 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Sertraline takers OR: 1.06 [0.99, 1.14] Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20
PPM002951 PGS000908
(PRS_Insomnia)
PSS001289|
European Ancestry|
4,362 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Escitalopram takers OR: 1.12 [1.03, 1.21] Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20
PPM002952 PGS000908
(PRS_Insomnia)
PSS001294|
European Ancestry|
3,964 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Venlafaxine takers OR: 1.03 [0.95, 1.11] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002953 PGS000908
(PRS_Insomnia)
PSS001285|
European Ancestry|
1,655 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Amitriptyline takers OR: 1.28 [1.07, 1.52] Variance explained (Nagelkerke's R2*100): 1.03 sex, age at study enrollment, genetic PCs 1-20
PPM002954 PGS000908
(PRS_Insomnia)
PSS001291|
European Ancestry|
1,986 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Mirtazapine takers OR: 1.03 [0.88, 1.2] Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20
PPM002955 PGS000908
(PRS_Insomnia)
PSS001287|
European Ancestry|
2,523 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Desvenlafaxine takers OR: 1.13 [1.03, 1.25] Variance explained (Nagelkerke's R2*100): 0.38 sex, age at study enrollment, genetic PCs 1-20
PPM002956 PGS000908
(PRS_Insomnia)
PSS001286|
European Ancestry|
2,585 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Citalopram takers OR: 1.08 [0.96, 1.21] Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20
PPM002957 PGS000908
(PRS_Insomnia)
PSS001290|
European Ancestry|
3,665 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Fluoxetine takers OR: 1.03 [0.94, 1.13] Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20
PPM002958 PGS000908
(PRS_Insomnia)
PSS001288|
European Ancestry|
1,994 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Duloxetine takers OR: 1.14 [1.02, 1.28] Variance explained (Nagelkerke's R2*100): 0.4 sex, age at study enrollment, genetic PCs 1-20
PPM002959 PGS000908
(PRS_Insomnia)
PSS001292|
European Ancestry|
1,577 individuals
PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
Reported Trait: Insomnia in Paroxetine takers OR: 1.16 [1.01, 1.33] Variance explained (Nagelkerke's R2*100): 0.47 sex, age at study enrollment, genetic PCs 1-20
PPM007457 PGS000926
(GBE_QT_FC1001220)
PSS007536|
African Ancestry|
6,254 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) : 0.02468 [0.01723, 0.03213]
Incremental R2 (full-covars): -0.00089
PGS R2 (no covariates): 0.00034 [-0.00056, 0.00125]
age, sex, UKB array type, Genotype PCs
PPM007458 PGS000926
(GBE_QT_FC1001220)
PSS007537|
East Asian Ancestry|
1,629 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Incremental R2 (full-covars): 0.00183
: 0.03667 [0.01919, 0.05415]
PGS R2 (no covariates): 0.00244 [-0.00223, 0.0071]
age, sex, UKB array type, Genotype PCs
PPM007459 PGS000926
(GBE_QT_FC1001220)
PSS007538|
European Ancestry|
24,713 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) : 0.02067 [0.01717, 0.02417]
Incremental R2 (full-covars): 0.00439
PGS R2 (no covariates): 0.00422 [0.00261, 0.00583]
age, sex, UKB array type, Genotype PCs
PPM007460 PGS000926
(GBE_QT_FC1001220)
PSS007539|
South Asian Ancestry|
7,410 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) : 0.0158 [0.01032, 0.02128]
Incremental R2 (full-covars): 0.00236
PGS R2 (no covariates): 0.00251 [0.0003, 0.00473]
age, sex, UKB array type, Genotype PCs
PPM007461 PGS000926
(GBE_QT_FC1001220)
PSS007540|
European Ancestry|
67,196 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) : 0.02284 [0.02061, 0.02507]
Incremental R2 (full-covars): 0.00532
PGS R2 (no covariates): 0.00542 [0.00431, 0.00652]
age, sex, UKB array type, Genotype PCs
PPM007472 PGS000929
(GBE_HC1583)
PSS004302|
African Ancestry|
6,497 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD all cause dementia AUROC: 0.87071 [0.81635, 0.92507] : 0.20833
Incremental AUROC (full-covars): 0.0113
PGS R2 (no covariates): 0.01979
PGS AUROC (no covariates): 0.61107 [0.52126, 0.70088]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007473 PGS000929
(GBE_HC1583)
PSS004303|
East Asian Ancestry|
1,704 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD all cause dementia AUROC: 0.95182 [0.90381, 0.99984] : 0.22288
Incremental AUROC (full-covars): 0.00617
PGS R2 (no covariates): 0.01638
PGS AUROC (no covariates): 0.54656 [0.0, 1.0]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007474 PGS000929
(GBE_HC1583)
PSS004304|
European Ancestry|
24,905 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD all cause dementia AUROC: 0.81502 [0.78, 0.85005] : 0.12968
Incremental AUROC (full-covars): 0.00636
PGS R2 (no covariates): 0.01492
PGS AUROC (no covariates): 0.59229 [0.54215, 0.64242]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007475 PGS000929
(GBE_HC1583)
PSS004305|
South Asian Ancestry|
7,831 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD all cause dementia AUROC: 0.82116 [0.74776, 0.89457] : 0.1345
Incremental AUROC (full-covars): 0.00919
PGS R2 (no covariates): 0.02074
PGS AUROC (no covariates): 0.56393 [0.44983, 0.67804]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007476 PGS000929
(GBE_HC1583)
PSS004306|
European Ancestry|
67,425 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD all cause dementia AUROC: 0.81557 [0.79434, 0.8368] : 0.11649
Incremental AUROC (full-covars): 0.02294
PGS R2 (no covariates): 0.02346
PGS AUROC (no covariates): 0.62703 [0.59629, 0.65777]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007551 PGS000945
(GBE_HC710)
PSS004614|
African Ancestry|
6,497 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE dementia in alzheimer's disease AUROC: 0.98515 [0.97381, 0.9965] : 0.33632
Incremental AUROC (full-covars): 0.00807
PGS R2 (no covariates): 0.02667
PGS AUROC (no covariates): 0.7414 [0.59579, 0.88702]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007552 PGS000945
(GBE_HC710)
PSS004615|
European Ancestry|
24,905 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE dementia in alzheimer's disease AUROC: 0.8807 [0.81377, 0.94763] : 0.16889
Incremental AUROC (full-covars): 0.0235
PGS R2 (no covariates): 0.04331
PGS AUROC (no covariates): 0.66609 [0.55451, 0.77766]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007553 PGS000945
(GBE_HC710)
PSS004616|
South Asian Ancestry|
7,831 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE dementia in alzheimer's disease AUROC: 0.9584 [0.92052, 0.99629] : 0.25982
Incremental AUROC (full-covars): 0.0131
PGS R2 (no covariates): 0.0675
PGS AUROC (no covariates): 0.67849 [0.36185, 0.99513]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007554 PGS000945
(GBE_HC710)
PSS004617|
European Ancestry|
67,425 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE dementia in alzheimer's disease AUROC: 0.8916 [0.86249, 0.9207] : 0.16679
Incremental AUROC (full-covars): 0.05458
PGS R2 (no covariates): 0.06543
PGS AUROC (no covariates): 0.75273 [0.69847, 0.80699]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007555 PGS000946
(GBE_HC713)
PSS004622|
African Ancestry|
6,497 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE unspecified dementia AUROC: 0.82014 [0.73087, 0.90941] : 0.13536
Incremental AUROC (full-covars): 0.02407
PGS R2 (no covariates): 0.01431
PGS AUROC (no covariates): 0.57071 [0.42666, 0.71476]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007556 PGS000946
(GBE_HC713)
PSS004624|
European Ancestry|
24,905 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE unspecified dementia AUROC: 0.82275 [0.77979, 0.86571] : 0.12092
Incremental AUROC (full-covars): 0.00342
PGS R2 (no covariates): 0.00838
PGS AUROC (no covariates): 0.57672 [0.50856, 0.64487]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007557 PGS000946
(GBE_HC713)
PSS004625|
South Asian Ancestry|
7,831 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE unspecified dementia AUROC: 0.90804 [0.86257, 0.9535] : 0.20027
Incremental AUROC (full-covars): 0.0061
PGS R2 (no covariates): 0.0151
PGS AUROC (no covariates): 0.56115 [0.41165, 0.71066]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM007558 PGS000946
(GBE_HC713)
PSS004626|
European Ancestry|
67,425 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE unspecified dementia AUROC: 0.83545 [0.80839, 0.8625] : 0.11896
Incremental AUROC (full-covars): 0.02339
PGS R2 (no covariates): 0.02543
PGS AUROC (no covariates): 0.64149 [0.59989, 0.68308]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM008585 PGS001179
(GBE_HC711)
PSS004618|
African Ancestry|
6,497 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE vascular dementia AUROC: 0.89609 [0.78011, 1.0] : 0.23133
Incremental AUROC (full-covars): -0.00271
PGS R2 (no covariates): 0.00098
PGS AUROC (no covariates): 0.45314 [0.26337, 0.6429]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM008586 PGS001179
(GBE_HC711)
PSS004619|
European Ancestry|
24,905 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE vascular dementia AUROC: 0.86436 [0.80883, 0.91989] : 0.14328
Incremental AUROC (full-covars): 0.00289
PGS R2 (no covariates): 0.00776
PGS AUROC (no covariates): 0.59245 [0.49395, 0.69095]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM008587 PGS001179
(GBE_HC711)
PSS004620|
South Asian Ancestry|
7,831 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE vascular dementia AUROC: 0.83842 [0.72824, 0.9486] : 0.14604
Incremental AUROC (full-covars): 0.00843
PGS R2 (no covariates): 0.0135
PGS AUROC (no covariates): 0.61894 [0.47358, 0.76431]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM008588 PGS001179
(GBE_HC711)
PSS004621|
European Ancestry|
67,425 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE vascular dementia AUROC: 0.82562 [0.78593, 0.86531] : 0.10475
Incremental AUROC (full-covars): 0.00707
PGS R2 (no covariates): 0.01123
PGS AUROC (no covariates): 0.61306 [0.55366, 0.67245]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009221 PGS001348
(GBE_HC1584)
PSS004307|
African Ancestry|
6,497 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD alzheimer's disease AUROC: 0.96694 [0.94819, 0.98568] : 0.31464
Incremental AUROC (full-covars): 0.01598
PGS R2 (no covariates): 0.04322
PGS AUROC (no covariates): 0.69389 [0.49462, 0.89316]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009222 PGS001348
(GBE_HC1584)
PSS004309|
European Ancestry|
24,905 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD alzheimer's disease AUROC: 0.8626 [0.81314, 0.91206] : 0.15552
Incremental AUROC (full-covars): 0.03113
PGS R2 (no covariates): 0.05179
PGS AUROC (no covariates): 0.66389 [0.57085, 0.75693]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009223 PGS001348
(GBE_HC1584)
PSS004310|
South Asian Ancestry|
7,831 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD alzheimer's disease AUROC: 0.91522 [0.82612, 1.0] : 0.23563
Incremental AUROC (full-covars): 0.0091
PGS R2 (no covariates): 0.01731
PGS AUROC (no covariates): 0.59348 [0.39906, 0.7879]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009224 PGS001348
(GBE_HC1584)
PSS004311|
European Ancestry|
67,425 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: AD alzheimer's disease AUROC: 0.8686 [0.84242, 0.89478] : 0.1517
Incremental AUROC (full-covars): 0.05292
PGS R2 (no covariates): 0.05685
PGS AUROC (no covariates): 0.72349 [0.67813, 0.76886]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009225 PGS001349
(GBE_HC807)
PSS004632|
African Ancestry|
6,497 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE alzheimer's disease AUROC: 0.96248 [0.93046, 0.9945] : 0.31063
Incremental AUROC (full-covars): 0.00757
PGS R2 (no covariates): 0.03204
PGS AUROC (no covariates): 0.63583 [0.42385, 0.84781]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009226 PGS001349
(GBE_HC807)
PSS004634|
European Ancestry|
24,905 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE alzheimer's disease AUROC: 0.86841 [0.82079, 0.91602] : 0.16057
Incremental AUROC (full-covars): 0.03323
PGS R2 (no covariates): 0.05188
PGS AUROC (no covariates): 0.67961 [0.58969, 0.76952]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009227 PGS001349
(GBE_HC807)
PSS004635|
South Asian Ancestry|
7,831 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE alzheimer's disease AUROC: 0.9136 [0.8364, 0.9908] : 0.24293
Incremental AUROC (full-covars): 0.00891
PGS R2 (no covariates): 0.01019
PGS AUROC (no covariates): 0.53145 [0.34417, 0.71873]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009228 PGS001349
(GBE_HC807)
PSS004636|
European Ancestry|
67,425 individuals
PGP000244 |
Tanigawa Y et al. PLoS Genet (2022)
Reported Trait: TTE alzheimer's disease AUROC: 0.8666 [0.84246, 0.89075] : 0.15418
Incremental AUROC (full-covars): 0.04665
PGS R2 (no covariates): 0.05271
PGS AUROC (no covariates): 0.71238 [0.66844, 0.75632]
age, sex, UKB array type, Genotype PCs Full Model & PGS R2 is estimated using Nagelkerke's method
PPM009238 PGS001775
(PRS39_AD)
PSS007663|
European Ancestry|
532 individuals
PGP000255 |
Ebenau JL et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Other dementia (excluding all-type dementia and Alzheimer's disease) HR: 0.5 [0.3, 0.9] Age, sex, population substructure, Mini-Mental State Examination (predictor: APOE ε4 allele or normalized PRS, outcome: clinical progression to dementia)
PPM009237 PGS001775
(PRS39_AD)
PSS007663|
European Ancestry|
532 individuals
PGP000255 |
Ebenau JL et al. Alzheimers Dement (Amst) (2021)
Reported Trait: Alzheimer's disease dementia HR: 1.7 [1.1, 2.8] Age, sex, population substructure, Mini-Mental State Examination (predictor: APOE ε4 allele or normalized PRS, outcome: clinical progression to dementia)
PPM009509 PGS001827
(portability-PLR_290.1)
PSS009297|
European Ancestry|
19,618 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0455 [0.0315, 0.0595] sex, age, birth date, deprivation index, 16 PCs
PPM009510 PGS001827
(portability-PLR_290.1)
PSS009071|
European Ancestry|
4,070 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.025 [-0.0058, 0.0558] sex, age, birth date, deprivation index, 16 PCs
PPM009511 PGS001827
(portability-PLR_290.1)
PSS008625|
European Ancestry|
6,562 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0324 [0.0081, 0.0565] sex, age, birth date, deprivation index, 16 PCs
PPM009512 PGS001827
(portability-PLR_290.1)
PSS008399|
Greater Middle Eastern Ancestry|
1,186 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0695 [0.0122, 0.1264] sex, age, birth date, deprivation index, 16 PCs
PPM009513 PGS001827
(portability-PLR_290.1)
PSS008179|
South Asian Ancestry|
6,222 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.046 [0.0211, 0.0708] sex, age, birth date, deprivation index, 16 PCs
PPM009514 PGS001827
(portability-PLR_290.1)
PSS007964|
East Asian Ancestry|
1,802 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0477 [0.0013, 0.094] sex, age, birth date, deprivation index, 16 PCs
PPM009515 PGS001827
(portability-PLR_290.1)
PSS007745|
African Ancestry|
2,441 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0445 [0.0047, 0.0842] sex, age, birth date, deprivation index, 16 PCs
PPM009516 PGS001827
(portability-PLR_290.1)
PSS008849|
African Ancestry|
3,852 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0522 [0.0206, 0.0837] sex, age, birth date, deprivation index, 16 PCs
PPM009517 PGS001828
(portability-PLR_290.11)
PSS009298|
European Ancestry|
19,563 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.0482 [0.0342, 0.0622] sex, age, birth date, deprivation index, 16 PCs
PPM009519 PGS001828
(portability-PLR_290.11)
PSS008626|
European Ancestry|
6,544 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.0354 [0.0111, 0.0596] sex, age, birth date, deprivation index, 16 PCs
PPM009520 PGS001828
(portability-PLR_290.11)
PSS008400|
Greater Middle Eastern Ancestry|
1,183 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.0684 [0.011, 0.1254] sex, age, birth date, deprivation index, 16 PCs
PPM009521 PGS001828
(portability-PLR_290.11)
PSS008180|
South Asian Ancestry|
6,205 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.0283 [0.0034, 0.0532] sex, age, birth date, deprivation index, 16 PCs
PPM009522 PGS001828
(portability-PLR_290.11)
PSS007965|
East Asian Ancestry|
1,802 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.045 [-0.0015, 0.0912] sex, age, birth date, deprivation index, 16 PCs
PPM009523 PGS001828
(portability-PLR_290.11)
PSS007746|
African Ancestry|
2,429 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.0414 [0.0015, 0.0812] sex, age, birth date, deprivation index, 16 PCs
PPM009524 PGS001828
(portability-PLR_290.11)
PSS008850|
African Ancestry|
3,836 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): 0.0338 [0.002, 0.0654] sex, age, birth date, deprivation index, 16 PCs
PPM009518 PGS001828
(portability-PLR_290.11)
PSS009072|
European Ancestry|
4,062 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Alzheimer's disease Partial Correlation (partial-r): -0.0098 [-0.0406, 0.021] sex, age, birth date, deprivation index, 16 PCs
PPM009528 PGS001829
(portability-PLR_296.2)
PSS008401|
Greater Middle Eastern Ancestry|
1,055 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0527 [-0.0082, 0.1133] sex, age, birth date, deprivation index, 16 PCs
PPM009529 PGS001829
(portability-PLR_296.2)
PSS008181|
South Asian Ancestry|
5,870 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): -0.0051 [-0.0307, 0.0205] sex, age, birth date, deprivation index, 16 PCs
PPM009531 PGS001829
(portability-PLR_296.2)
PSS007747|
African Ancestry|
2,272 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): -0.0294 [-0.0706, 0.0119] sex, age, birth date, deprivation index, 16 PCs
PPM009532 PGS001829
(portability-PLR_296.2)
PSS008851|
African Ancestry|
3,678 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0034 [-0.029, 0.0358] sex, age, birth date, deprivation index, 16 PCs
PPM009525 PGS001829
(portability-PLR_296.2)
PSS009299|
European Ancestry|
17,764 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0323 [0.0176, 0.047] sex, age, birth date, deprivation index, 16 PCs
PPM009526 PGS001829
(portability-PLR_296.2)
PSS009073|
European Ancestry|
3,729 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0074 [-0.0248, 0.0396] sex, age, birth date, deprivation index, 16 PCs
PPM009527 PGS001829
(portability-PLR_296.2)
PSS008627|
European Ancestry|
5,989 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.027 [0.0017, 0.0524] sex, age, birth date, deprivation index, 16 PCs
PPM009530 PGS001829
(portability-PLR_296.2)
PSS007966|
East Asian Ancestry|
1,742 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0274 [-0.0199, 0.0745] sex, age, birth date, deprivation index, 16 PCs
PPM009533 PGS001830
(portability-PLR_318)
PSS009300|
European Ancestry|
19,400 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0557 [0.0416, 0.0697] sex, age, birth date, deprivation index, 16 PCs
PPM009534 PGS001830
(portability-PLR_318)
PSS009074|
European Ancestry|
4,022 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0092 [-0.0218, 0.0401] sex, age, birth date, deprivation index, 16 PCs
PPM009535 PGS001830
(portability-PLR_318)
PSS008628|
European Ancestry|
6,548 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0603 [0.0361, 0.0845] sex, age, birth date, deprivation index, 16 PCs
PPM009536 PGS001830
(portability-PLR_318)
PSS008402|
Greater Middle Eastern Ancestry|
1,180 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0076 [-0.05, 0.0651] sex, age, birth date, deprivation index, 16 PCs
PPM009537 PGS001830
(portability-PLR_318)
PSS008182|
South Asian Ancestry|
6,249 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0361 [0.0113, 0.0609] sex, age, birth date, deprivation index, 16 PCs
PPM009538 PGS001830
(portability-PLR_318)
PSS007967|
East Asian Ancestry|
1,800 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0404 [-0.0061, 0.0867] sex, age, birth date, deprivation index, 16 PCs
PPM009539 PGS001830
(portability-PLR_318)
PSS007748|
African Ancestry|
2,445 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): -0.0084 [-0.0482, 0.0314] sex, age, birth date, deprivation index, 16 PCs
PPM009540 PGS001830
(portability-PLR_318)
PSS008852|
African Ancestry|
3,876 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0032 [-0.0284, 0.0347] sex, age, birth date, deprivation index, 16 PCs
PPM010331 PGS001932
(portability-PLR_insomnia)
PSS009419|
European Ancestry|
19,978 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.1248 [0.1111, 0.1384] sex, age, birth date, deprivation index, 16 PCs
PPM010332 PGS001932
(portability-PLR_insomnia)
PSS009193|
European Ancestry|
4,116 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.1003 [0.0699, 0.1305] sex, age, birth date, deprivation index, 16 PCs
PPM010333 PGS001932
(portability-PLR_insomnia)
PSS008747|
European Ancestry|
6,626 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.1093 [0.0854, 0.133] sex, age, birth date, deprivation index, 16 PCs
PPM010334 PGS001932
(portability-PLR_insomnia)
PSS008521|
Greater Middle Eastern Ancestry|
1,153 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.0776 [0.0195, 0.1353] sex, age, birth date, deprivation index, 16 PCs
PPM010335 PGS001932
(portability-PLR_insomnia)
PSS008299|
South Asian Ancestry|
6,199 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.0768 [0.052, 0.1015] sex, age, birth date, deprivation index, 16 PCs
PPM010337 PGS001932
(portability-PLR_insomnia)
PSS007863|
African Ancestry|
2,460 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.0475 [0.0078, 0.087] sex, age, birth date, deprivation index, 16 PCs
PPM010338 PGS001932
(portability-PLR_insomnia)
PSS008967|
African Ancestry|
3,863 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.033 [0.0013, 0.0645] sex, age, birth date, deprivation index, 16 PCs
PPM010336 PGS001932
(portability-PLR_insomnia)
PSS008076|
East Asian Ancestry|
1,788 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Sleeplessness / insomnia Partial Correlation (partial-r): 0.0473 sex, age, birth date, deprivation index, 16 PCs
PPM010835 PGS001995
(portability-PLR_narcolepsy)
PSS009478|
European Ancestry|
19,922 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0959 [0.0822, 0.1097] sex, age, birth date, deprivation index, 16 PCs
PPM010836 PGS001995
(portability-PLR_narcolepsy)
PSS009252|
European Ancestry|
4,057 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0898 [0.0591, 0.1203] sex, age, birth date, deprivation index, 16 PCs
PPM010837 PGS001995
(portability-PLR_narcolepsy)
PSS008806|
European Ancestry|
6,571 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0631 [0.039, 0.0872] sex, age, birth date, deprivation index, 16 PCs
PPM010838 PGS001995
(portability-PLR_narcolepsy)
PSS008580|
Greater Middle Eastern Ancestry|
1,078 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0622 [0.002, 0.1221] sex, age, birth date, deprivation index, 16 PCs
PPM010839 PGS001995
(portability-PLR_narcolepsy)
PSS008358|
South Asian Ancestry|
6,001 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0739 [0.0487, 0.0991] sex, age, birth date, deprivation index, 16 PCs
PPM010840 PGS001995
(portability-PLR_narcolepsy)
PSS008135|
East Asian Ancestry|
1,752 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0367 [-0.0104, 0.0837] sex, age, birth date, deprivation index, 16 PCs
PPM010841 PGS001995
(portability-PLR_narcolepsy)
PSS007922|
African Ancestry|
2,395 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0267 [-0.0135, 0.0668] sex, age, birth date, deprivation index, 16 PCs
PPM010842 PGS001995
(portability-PLR_narcolepsy)
PSS009026|
African Ancestry|
3,750 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Daytime dozing / sleeping (narcolepsy) Partial Correlation (partial-r): 0.0356 [0.0036, 0.0677] sex, age, birth date, deprivation index, 16 PCs
PPM011147 PGS002035
(portability-ldpred2_290.1)
PSS009297|
European Ancestry|
19,618 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0425 [0.0285, 0.0564] sex, age, birth date, deprivation index, 16 PCs
PPM011148 PGS002035
(portability-ldpred2_290.1)
PSS009071|
European Ancestry|
4,070 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0206 [-0.0102, 0.0513] sex, age, birth date, deprivation index, 16 PCs
PPM011149 PGS002035
(portability-ldpred2_290.1)
PSS008625|
European Ancestry|
6,562 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0343 [0.0101, 0.0585] sex, age, birth date, deprivation index, 16 PCs
PPM011150 PGS002035
(portability-ldpred2_290.1)
PSS008399|
Greater Middle Eastern Ancestry|
1,186 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0658 [0.0084, 0.1227] sex, age, birth date, deprivation index, 16 PCs
PPM011151 PGS002035
(portability-ldpred2_290.1)
PSS008179|
South Asian Ancestry|
6,222 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0453 [0.0205, 0.0701] sex, age, birth date, deprivation index, 16 PCs
PPM011152 PGS002035
(portability-ldpred2_290.1)
PSS007964|
East Asian Ancestry|
1,802 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.0494 [0.003, 0.0956] sex, age, birth date, deprivation index, 16 PCs
PPM011153 PGS002035
(portability-ldpred2_290.1)
PSS007745|
African Ancestry|
2,441 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.044 [0.0042, 0.0837] sex, age, birth date, deprivation index, 16 PCs
PPM011154 PGS002035
(portability-ldpred2_290.1)
PSS008849|
African Ancestry|
3,852 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Dementias Partial Correlation (partial-r): 0.04 [0.0083, 0.0715] sex, age, birth date, deprivation index, 16 PCs
PPM011155 PGS002036
(portability-ldpred2_296.2)
PSS009299|
European Ancestry|
17,764 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0556 [0.041, 0.0703] sex, age, birth date, deprivation index, 16 PCs
PPM011156 PGS002036
(portability-ldpred2_296.2)
PSS009073|
European Ancestry|
3,729 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0583 [0.0261, 0.0903] sex, age, birth date, deprivation index, 16 PCs
PPM011158 PGS002036
(portability-ldpred2_296.2)
PSS008401|
Greater Middle Eastern Ancestry|
1,055 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0239 [-0.0371, 0.0847] sex, age, birth date, deprivation index, 16 PCs
PPM011159 PGS002036
(portability-ldpred2_296.2)
PSS008181|
South Asian Ancestry|
5,870 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0224 [-0.0033, 0.048] sex, age, birth date, deprivation index, 16 PCs
PPM011160 PGS002036
(portability-ldpred2_296.2)
PSS007966|
East Asian Ancestry|
1,742 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0549 [0.0077, 0.1019] sex, age, birth date, deprivation index, 16 PCs
PPM011161 PGS002036
(portability-ldpred2_296.2)
PSS007747|
African Ancestry|
2,272 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0029 [-0.0384, 0.0442] sex, age, birth date, deprivation index, 16 PCs
PPM011162 PGS002036
(portability-ldpred2_296.2)
PSS008851|
African Ancestry|
3,678 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0178 [-0.0147, 0.0501] sex, age, birth date, deprivation index, 16 PCs
PPM011157 PGS002036
(portability-ldpred2_296.2)
PSS008627|
European Ancestry|
5,989 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Depression Partial Correlation (partial-r): 0.0415 [0.0162, 0.0668] sex, age, birth date, deprivation index, 16 PCs
PPM011163 PGS002037
(portability-ldpred2_318)
PSS009300|
European Ancestry|
19,400 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0741 [0.0601, 0.0881] sex, age, birth date, deprivation index, 16 PCs
PPM011164 PGS002037
(portability-ldpred2_318)
PSS009074|
European Ancestry|
4,022 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0253 [-0.0056, 0.0563] sex, age, birth date, deprivation index, 16 PCs
PPM011166 PGS002037
(portability-ldpred2_318)
PSS008402|
Greater Middle Eastern Ancestry|
1,180 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.043 [-0.0146, 0.1003] sex, age, birth date, deprivation index, 16 PCs
PPM011167 PGS002037
(portability-ldpred2_318)
PSS008182|
South Asian Ancestry|
6,249 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0598 [0.035, 0.0845] sex, age, birth date, deprivation index, 16 PCs
PPM011168 PGS002037
(portability-ldpred2_318)
PSS007967|
East Asian Ancestry|
1,800 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0244 [-0.0221, 0.0708] sex, age, birth date, deprivation index, 16 PCs
PPM011169 PGS002037
(portability-ldpred2_318)
PSS007748|
African Ancestry|
2,445 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): 0.0244 [-0.0154, 0.0642] sex, age, birth date, deprivation index, 16 PCs
PPM011170 PGS002037
(portability-ldpred2_318)
PSS008852|
African Ancestry|
3,876 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder Partial Correlation (partial-r): -0.0199 [-0.0514, 0.0117] sex, age, birth date, deprivation index, 16 PCs
PPM011165 PGS002037
(portability-ldpred2_318)
PSS008628|
European Ancestry|
6,548 individuals
PGP000263 |
Privé F et al. Am J Hum Genet (2022)
Reported Trait: Tobacco use disorder